,qtr,Form_Type,Company_Name,CIK,Date,Path,Indicator,Phrase
0,q4-15,10-K,HOLOGIC INC,859737,2015-11-19,http://www.sec.gov/Archives/edgar/data/859737/000085973715000034,No,"No customer accounted for 10% or greater of our total revenue in the three-month periods ended September 30, 2015 and 2014, or in the nine-month periods ended September 30, 2015 and 2014. "
1,q4-15,10-K,HOLOGIC INC,859737,2015-11-19,http://www.sec.gov/Archives/edgar/data/859737/000085973715000034,No,"In the aggregate, the businesses acquired during the first three quarters of fiscal 2015 collectively contributed less than two percent to the Company's total revenue during the first three quarters of fiscal 2015."
2,q4-15,10-K,HOLOGIC INC,859737,2015-11-19,http://www.sec.gov/Archives/edgar/data/859737/000085973715000034,No," The majority of the Company s revenues are comprised of: 1) transaction-based fees, which typically constitute a percentage of dollar volume processed; 2) fees per transaction processed; 3) fees per account on file during the period; or 4) some combination thereof."
3,q4-15,10-Q,"HCA Holdings, Inc.",860730,2015-10-29,http://www.sec.gov/Archives/edgar/data/860730/000119312515358150,No,"Coca-Cola Refreshments USA Inc. (&#x201C;CCR&#x201D;) accounted for approximately 41% and 28% of the Company s net sales for the three-months ended September 30, 2015 and 2014, respectively."
4,q4-15,10-Q,"HCA Holdings, Inc.",860730,2015-10-29,http://www.sec.gov/Archives/edgar/data/860730/000119312515358150,No,"One of these contracts accounted for approximately 2%, 3% and 4% of the Company's revenue in the years ended September 30, 2015, 2014 and 2013, respectively. "
5,q4-15,10-Q,"HCA Holdings, Inc.",860730,2015-10-29,http://www.sec.gov/Archives/edgar/data/860730/000119312515358150,No,"Customers who accounted for 10% or more of our net revenues during the three months ended September 30, 2015 are as follows:     Barnes   Noble   22% <td style=""width: 0.75in; font-family: 'times new roman', times, serif;"">   Hewlett Packard Company   21%   Autoliv Development AB   18%   Customers who accounted for 10% or more of our net revenues during the nine months ended September 30, 2015 are as follows:     Hewlett Packard Company  26%   Amazon   15%   Autoliv Development AB   18%   Our net revenues for the three and nine months ended September 30, 2014 were earned from sixteen and twenty-eight customers."
6,q4-15,10-Q,SAFEGUARD SCIENTIFICS INC,86115,2015-10-23,http://www.sec.gov/Archives/edgar/data/86115/000008611515000087,No,"For the year ended December 31, 2014, Dana represented approximately 59% of our net revenue."
7,q4-15,10-K,FEMALE HEALTH CO,863894,2015-12-02,http://www.sec.gov/Archives/edgar/data/863894/000086389415000009,No,"During the year ended December 31, 2013, three customers accounted for 100% of the Company s revenue. "
8,q4-15,10-Q,SYPRIS SOLUTIONS INC,864240,2015-11-17,http://www.sec.gov/Archives/edgar/data/864240/000143774915021036,No,"Sinopharm contributed 92% and 93% of the Company s total net revenue for the nine-month periods ended September 30, 2015 and 2014, respectively."
9,q4-15,10-Q,SIMON WORLDWIDE INC,864264,2015-11-13,http://www.sec.gov/Archives/edgar/data/864264/000119312515376994,No,"Midstream   Marketing   UGI International       Total   Elim- inations   AmeriGas Propane   Gas Utility   Energy Services   Electric Generation   UGI France   Flaga   Other   Corporate   Other (b) 2015                                   Revenues $ 6,691.1   $ (232.6 ) (c) $ 2,885.3   $ 933.1   $ 1,041.8   $ 75.9   $ 1,122.2   $ 686.3   $ 179.1 Cost of sales $ 3,736.5   $ (228.8 ) (c) $ 1,340.0   $ 448.6   $ 800.9   $ 32.2   $ 628.0   $ 492.0   $ 223.6 Operating income (loss) $ 834.9   $ (0.9 )   $ 427.6   $ 226.5   $ 171.8   $ 13.0   $ 75.9   $ 36.9   $ (115.9 ) Loss from equity investees (1.2 )                       (1.2 )         Interest expense (241.9 )       (162.8 )   (39.1 )   (2.1 )       (31.6 ) (d) (3.6 )   (2.7 ) Income (loss) before income taxes $ 591.8   $ (0.9 )   $ 264.8   $ 187.4   $ 169.7   $ 13.0   $ 43.1   $ 33.3   $ (118.6 ) Net income (loss) attributable to UGI $ 281.0   $ (0.6 )   $ 61.0   $ 115.8   $ 99.3   $ 9.6   $ 27.5   $ 25.2   $ (56.8 ) Depreciation and amortization $ 374.1   $     $ 194.9   $ 59.0   $ 14.6   $ 12.5   $ 63.7   $ 23.2   $ 6.2 Noncontrolling interests  net income (loss) $ 133.0   $     $ 167.9   $     $     $     $     $ (0.1 )   $ (34.8 ) Partnership Adjusted EBITDA (a)       $ 619.2                                           Midstream   Marketing   UGI International       Total   Elim- inations   AmeriGas Propane   Gas Utility   Energy Services   Electric Generation   UGI France   Flaga   Other   Corporate   Other (b) Total assets $ 10,546.6   $ (90.4 )   $ 4,150.0   $ 2,362.4   $ 664.3   $ 282.0   $ 2,340.4   $ 529.1   $ 308.8 Short-term borrowings $ 189.9   $     $ 68.1   $ 71.7   $ 49.5   $     $ 0.1   $ 0.5   $   Capital expenditures $ 475.4   $     $ 102.0   $ 189.7   $ 71.5   $ 16.7   $ 65.0   $ 22.5   $ 8.0 Investments in equity investees $ 16.2   $     $     $     $ 6.4   $     $ 6.0   $ 3.8   $   Goodwill $ 2,953.4   $     $ 1,956.0   $ 182.1   $ 5.6   $     $ 721.4   $ 82.3   $ 6.0                                     2014                                   Revenues $ 8,277.3   $ (321.3 ) (c) $ 3,712.9   $ 977.3   $ 1,305.5   $ 85.1   $ 1,295.5   $ 1,026.9   $ 195.4 Cost of sales $ 5,175.7   $ (317.7 ) (c) $ 2,107.1   $ 496.8   $ 1,058.8   $ 39.6   $ 848.1   $ 809.9   $ 133.1 Operating income (loss) $ 1,005.6   $ 0.2   $ 472.0   $ 236.2   $ 180.5   $ 18.1   $ 79.1   $ 38.4   $ (18.9 ) Loss from equity investees (0.1 )                       (0.1 )         Interest expense (237.7 )       (165.6 )   (36.6 )   (2.9 )       (25.1 )   (4.9 )   (2.6 ) Income (loss) before income taxes 767.8   0.2   306.4   199.6   177.6   18.1   53.9   33.5   (21.5 ) Net income (loss) attributable to UGI $ 337.2   $     $ 63.0   $ 118.8   $ 105.2   $ 12.6   $ 20.6   $ 27.7   $ (10.7 ) Depreciation and amortization $ 362.9   $     $ 197.2   $ 54.8   $ 12.3   $ 10.7   $ 54.5   $ 27.1   $ 6.3 Noncontrolling interests  net income (loss) $ 195.4   $     $ 195.8   $     $     $     $ (0.4 )   $     $   Partnership Adjusted EBITDA (a)       $ 664.8                         Total assets $ 10,093.0   $ (86.5 )   $ 4,377.0   $ 2,214.1   $ 569.0   $ 277.7   $ 1,659.1   $ 643.6   $ 439.0 Short-term borrowings $ 210.8   $     $ 109.0   $ 86.3   $ 7.5   $     $     $ 8.0   $   Capital expenditures $ 436.4   $     $ 113.9   $ 156.4   $ 67.8   $ 15.6   $ 50.2   $ 23.0   $ 9.5 Investments in equity investees $ 0.6   $     $     $     $     $     $     $ 0.6   $   Goodwill $ 2,833.4   $     $ 1,945.1   $ 182.1   $ 5.6   $     $ 601.2   $ 92.4   $ 7.0                                     2013                                   Revenues $ 7,194.7   $ (223.8 ) (c) $ 3,168.8   $ 839.0   $ 969.4   $ 71.4   $ 1,322.6   $ 856.6   $ 190.7 Cost of sales $ 4,324.4   $ (217.5 ) (c) $ 1,657.2   $ 407.2   $ 836.9   $ 39.9   $ 845.0   $ 653.4   $ 102.3 Operating income $ 831.1   $ (1.1 )   $ 394.4   $ 196.5   $ 82.5   $ 7.5   $ 111.4   $ 35.6   $ 4.3 Loss from equity investees (0.4 )                       (0.4 )         Interest expense (240.3 )       (166.6 )   (37.4 )   (3.2 )       (25.3 )   (5.1 )   (2.7 ) Income before income taxes $ 590.4   $ (1.1 )   $ 227.8   $ 159.1   $ 79.3   $ 7.5   $ 85.7   $ 30.5   $ 1.6 Net income attributable to UGI $ 278.1   $ (0.6 )   $ 47.5   $ 94.3   $ 46.3   $ 6.2   $ 57.2   $ 25.5   $ 1.7 Depreciation and amortization $ 363.1   $     $ 205.9   $ 51.7   $ 7.6   $ 10.0   $ 57.6   $ 24.1   $ 6.2 Noncontrolling interests  net income (loss) $ 149.5   $     $ 149.6   $     $     $     $ (0.2 )   $ 0.1   $   Partnership Adjusted EBITDA (a)         $ 596.5                         Total assets $ 10,008.8   $ (100.3 )   $ 4,429.3   $ 2,069.0   $ 501.2   $ 269.7   $ 1,784.4   $ 667.1   $ 388.4 Short-term borrowings $ 227.9   $     $ 116.9   $ 17.5   $ 87.0   $     $     $ 6.5   $   Capital expenditures $ 488.0   $ (1.1 )   $ 111.1   $ 144.4   $ 133.8   $ 22.6   $ 53.4   $ 17.4   $ 6.4 Investments in equity investees $ 0.3   $     $     $     $     $     $     $ 0.3   $   Goodwill $ 2,873.7   $     $ 1,941.0   $ 182.1   $ 2.8   $     $ 643.7   $ 97.1   $ 7.0 (a) The following table provides a reconciliation of Partnership Adjusted EBITDA to AmeriGas Propane operating income:     2015   2014   2013 Partnership Adjusted EBITDA   $ 619.2   $ 664.8   $ 596.5 Depreciation and amortization   (194.9 )   (197.2 )   (205.9 ) Noncontrolling interests (i)   3.3   4.4   3.8 Operating income   $ 427.6   $ 472.0   $ 394.4 (i) Principally represents the General Partner s 1.01% interest in AmeriGas OLP."
10,q4-15,10-Q,CASCADE MICROTECH INC,864559,2015-11-05,http://www.sec.gov/Archives/edgar/data/864559/000119312515366570,No,"Revenue and long-lived asset information are as follows (in thousands):   Three Months Ended   September 30,   Nine Months Ended   September 30,   2015   2014   2015   2014 Consolidated Revenue:               United States $ 62,553   $ 56,678   $ 177,627   $ 157,481 Foreign countries 32,030   33,198   98,288   104,343 Totals $ 94,583   $ 89,876   $ 275,915   $ 261,824   Three Months Ended   September 30,   Nine Months Ended   September 30,   2015   2014   2015   2014 Revenue by End Market:               Neurology Products               Devices and Systems $ 41,993   $ 43,922   $ 123,086   $ 125,917 Supplies 15,286   14,746   45,603   45,059 Services 2,125       5,614     Total Neurology Revenue 59,404   58,668   174,303   170,976 Newborn Care Products               Devices and Systems 17,598   16,516   53,916   49,064 Supplies 12,584   12,854   37,025   36,733 Services 4,997   1,838   10,671   5,051 Total Newborn Care Revenue 35,179   31,208   101,612   90,848 Total Revenue $ 94,583   $ 89,876   $ 275,915   $ 261,824   September 30, 2015   December 31, 2014 Property and equipment, net:       United States $ 6,367   $ 5,782 Canada 5,199   5,538 Argentina 3,271   3,692 Ireland 1,974   1,656 Other foreign countries 1,165   1,255 Totals $ 17,976   $ 17,923 During the three and nine months ended September 30, 2015 and 2014 , no single customer or foreign country contributed to more than 10% of revenue. "
11,q4-15,10-Q,TRIMBLE NAVIGATION LTD /CA/,864749,2015-11-10,http://www.sec.gov/Archives/edgar/data/864749/000086474915000061,No,"The following table represents total revenue by geographic area:        Three Months Ended September 30,      Nine Months Ended September 30,        2015      2014      2015      2014        (in thousands)   United States    $ 47,341       $ 39,734       $ 136,988       $ 100,404    Europe      8,470         10,207         29,572         35,830    Asia / Pacific      16,217         15,131         51,175         47,857    Other      6,386         6,458         19,285         22,016                                        Total    $ 78,414       $ 71,530       $ 237,020       $ 206,107                                        Total assets by geographic area are as follows:        September 30, 2015      December 31, 2014        (in thousands)   United States    $ 462,585       $ 420,513    Europe      21,526         23,235    Asia / Pacific      19,247         19,182    Eliminations      (5,591 )       (5,206 )                    Total    $ 497,767       $ 457,724                      Long-lived assets (property and equipment only) by geographic area are as follows:        September 30, 2015      December 31, 2014        (in thousands)   United States    $ 34,134       $ 30,912    Europe      1,540         1,656    Asia / Pacific      2,787         1,688                      Total    $ 38,461       $ 34,256                      No individual country within Europe or Asia/Pacific represented greater than 10% of total revenue, assets or long-lived assets for any period presented. "
12,q4-15,10-Q,Monster Beverage Corp,865752,2015-11-06,http://www.sec.gov/Archives/edgar/data/865752/000110465915076694,No,"For the three-month and nine-month periods ended September 30, 2015, one individual customer accounted for 74 percent and 76 percent of net product revenue, respectively."
13,q4-15,10-Q,Monster Beverage Corp,865752,2015-11-06,http://www.sec.gov/Archives/edgar/data/865752/000110465915076694,No,"The following distributors and customers accounted for 10% or more of the Company's revenue for the periods presented:   Three Months Ended   Nine Months Ended   September 27, 2015   September 28, 2014   September 27, 2015   September 28, 2014 Distributor ""A"" 15 %   26 %   24 %   15 % Distributor ""B"" *   12 %   *   * Customer ""B"" 10 %   13 %   14 %   * Customer ""G"" 57 %   27 %   44 %   53 %   * Represents less than 10% of revenue for the period presented."
14,q4-15,10-Q,Monster Beverage Corp,865752,2015-11-06,http://www.sec.gov/Archives/edgar/data/865752/000110465915076694,No,"As of November  6 , 2015, distribution rights in the U.S. representing approximately 89% of the target case sales (see Note 2) have been transitioned to TCCC s distribution network."
15,q4-15,10-Q,Monster Beverage Corp,865752,2015-11-06,http://www.sec.gov/Archives/edgar/data/865752/000110465915076694,No,"There were no customers with balances greater than 10% of accounts receivable as of September 26, 2015 and September 27, 2014 , or any customers that represented greater than 10% of consolidated revenues for fiscal years 2015 , 2014 and 2013 . "
16,q4-15,10-Q,Monster Beverage Corp,865752,2015-11-06,http://www.sec.gov/Archives/edgar/data/865752/000110465915076694,No,"Total assets for the two business segments as of September 30, 2015 and March 31, 2015 are as follows (in thousands):     September 30,     March 31,     2015     2015   Wind $ 34,391     $ 41,947   Grid   38,821       42,482   Corporate assets   61,048       49,396   Total $ 134,260     $ 133,825     The following table sets forth customers who represented 10% or more of the Company s total revenues for the three and six months ended September 30, 2015 and 2014:     Three months ended September 30,     Six months ended September 30,     2015     2014     2015     2014   INOX Wind Limited   66 %     48 %     55 %     48 % RES American Construction, Inc.   %     16 %     %    10 % Beijing JINGCHENG New Energy Co., Ltd  10 %     %     15 %    10 %                                   "
17,q4-15,10-Q,"ORBITAL ATK, INC.",866121,2015-11-05,http://www.sec.gov/Archives/edgar/data/866121/000086612115000052,No,"For the three months ended September 30, 2015, and 2014, respectively, two customers accounted in the aggregate for approximately 13% of the net sales of the Benchtop Laboratory Equipment Operations for each period, 11% and 9% of the Company s revenues."
18,q4-15,10-K,ESCO TECHNOLOGIES INC,866706,2015-11-30,http://www.sec.gov/Archives/edgar/data/866706/000114420415068633,No,"No one customer accounted for 10% or more of revenue during the six months ended September 30, 2014 or 2015."
19,q4-15,10-K,ESCO TECHNOLOGIES INC,866706,2015-11-30,http://www.sec.gov/Archives/edgar/data/866706/000114420415068633,No,"One class of similar products accounted for approximately 11 percent of the Company's total revenues,No other class of similar products accounted for 10 percent or more of total revenues"
20,q4-15,10-K,AUTOZONE INC,866787,2015-10-26,http://www.sec.gov/Archives/edgar/data/866787/000119312515353476,No,"No clients accounted for 10% of the Company s revenue for the three and nine months ended September 30, 2015 or for the three and nine months ended September 30, 2014 ."
21,q4-15,10-K,AUTOZONE INC,866787,2015-10-26,http://www.sec.gov/Archives/edgar/data/866787/000119312515353476,No,"The Company had two distributors that accounted for 16% and 10% , respectively, of net revenue in the nine months ended September 30, 2014 ."
22,q4-15,10-K,AUTOZONE INC,866787,2015-10-26,http://www.sec.gov/Archives/edgar/data/866787/000119312515353476,No,No single customer represents more than ten percent of our consolidated revenues.
23,q4-15,10-K,AUTOZONE INC,866787,2015-10-26,http://www.sec.gov/Archives/edgar/data/866787/000119312515353476,No,"For the year ended June 30, 2015, one customer accounted for approximately 45% of consolidated revenues."
24,q4-15,10-K,AUTOZONE INC,866787,2015-10-26,http://www.sec.gov/Archives/edgar/data/866787/000119312515353476,No,"In addition, we sold to the hedge counterparties warrants exercisable, on a cashless basis, for the sale of rights to receive shares of common stock that will initially underlie our February 2018 Notes at a strike price of $10.3610 per share, which represents a premium of approximately 30% over the last reported sale price of the Company's common stock of $7.97 on February 6, 2014."
25,q4-15,10-Q,LIGHTING SCIENCE GROUP CORP,866970,2015-11-13,http://www.sec.gov/Archives/edgar/data/866970/000143774915020780,No,"Condensed Consolidating Statements of Operations (in millions of U.S. dollars) Unaudited        For the Three Months Ended October 3, 2015        Cott Corporation     DS Services of America, Inc.     DSS Guarantor Subsidiaries     DSS Non-Guarantor Subsidiaries     Elimination Entries     Consolidated   Revenue, net    $ 37.0      $ 268.1      $ 431.3      $ 33.3      $ (14.1 )    $ 755.6    Cost of sales      31.4        104.3        375.2        26.3        (14.1 )      523.1                                                     Gross profit      5.6        163.8        56.1        7.0                   232.5    Selling, general and administrative expenses      6.0        142.5        44.2        3.5                   196.2    Loss on disposal of property, plant   equipment                 0.9        0.2                              1.1    Acquisition and integration expenses                 6.4        0.2                              6.6                                                     Operating (loss) income      (0.4 )      14.0        11.5        3.5                   28.6    Other expense (income), net      0.8        (0.6 )      0.3        0.1                   0.6    Intercompany interest expense (income), net                 10.8        (10.8 )                                   Interest expense, net                 7.4        20.0                              27.4                                                     (Loss) income before income tax (benefit) expense and equity income      (1.2 )      (3.6 )      2.0        3.4                   0.6    Income tax (benefit) expense      (0.2 )      (1.2 )      (4.3 )      (0.1 )                 (5.8 )  Equity income      5.8                   1.0                   (6.8 )                                                              Net income (loss)    $ 4.8      $ (2.4 )    $ 7.3      $ 3.5      $ (6.8 )    $ 6.4    Less: Net income attributable to non-controlling interests                                       1.6                   1.6                                                     Net income (loss) attributed to Cott Corporation    $ 4.8      $ (2.4 )    $ 7.3      $ 1.9      $ (6.8 )    $ 4.8                                                     Comprehensive (loss) income attributed to Cott Corporation    $ (8.9 )    $ (2.4 )    $ (19.8 )    $ 3.9      $ 18.3      $ (8.9 )                                                     Condensed Consolidating Statements of Operations (in millions of U.S. dollars) Unaudited        For the Nine Months Ended October 3, 2015        Cott Corporation     DS Services of America, Inc.     DSS Guarantor Subsidiaries     DSS Non-Guarantor Subsidiaries      Elimination Entries     Consolidated   Revenue, net    $ 113.9      $ 765.4      $ 1,307.1      $ 103.0       $ (44.2 )    $ 2,245.2    Cost of sales      96.8        305.5        1,129.6        83.1         (44.2 )      1,570.8                                                      Gross profit      17.1        459.9        177.5        19.9                    674.4    Selling, general and administrative expenses      16.4        418.8        130.1        9.6                    574.9    Loss (gain) on disposal of property, plant   equipment                 2.9        (0.2 )                             2.7    Acquisition and integration expenses                 12.5        2.9                               15.4                                                      Operating income      0.7        25.7        44.7        10.3                    81.4    Other (income) expense, net      (9.0 )      (1.0 )      1.1        0.1                    (8.8 )  Intercompany interest (income) expense, net      (4.9 )      32.7        (27.8 )                                    Interest expense, net      0.1        22.2        60.7                               83.0                                                      Income (loss) before income tax expense (benefit) and equity income      14.5        (28.2 )      10.7        10.2                    7.2    Income tax expense (benefit)      2.8        (10.2 )      (9.0 )      0.1                    (16.3 )  Equity income      7.2                   4.0                    (11.2 )                                                               Net income (loss)    $ 18.9      $ (18.0 )    $ 23.7      $ 10.1       $ (11.2 )    $ 23.5    Less: Net income attributable to non-controlling interests                                       4.6                    4.6    Less: Accumulated dividends on convertible preferred shares      4.5                                                     4.5    Less: Accumulated dividends on non-convertible preferred shares      1.4                                                     1.4    Less: Foreign exchange impact on redemption of preferred shares      12.0                                                     12.0                                                      Net income (loss) attributed to Cott Corporation    $ 1.0      $ (18.0 )    $ 23.7      $ 5.5       $ (11.2 )    $ 1.0                                                      Comprehensive (loss) income attributed to Cott Corporation    $ (16.3 )    $ (18.0 )    $ 23.7      $ 8.7       $ (14.4 )    $ (16.3 )                                                    Condensed Consolidating Statements of Operations (in millions of U.S. dollars) Unaudited        For the Three Months Ended September 27, 2014        Cott Corporation     DS Services of America, Inc.      DSS Guarantor Subsidiaries     DSS Non-Guarantor Subsidiaries      Elimination Entries     Consolidated   Revenue, net    $ 42.3      $           $ 469.8      $ 35.7       $ (12.8 )    $ 535.0    Cost of sales      36.2                    412.1        30.0         (12.8 )      465.5                                                       Gross profit      6.1                    57.7        5.7                    69.5    Selling, general and administrative expenses      5.5                    41.7        2.7                    49.9    Loss on disposal of property, plant   equipment      0.2                    0.2                               0.4    Restructuring      0.1                                                      0.1    Asset impairments                             (0.2 )                             (0.2 )  Acquisition and integration expenses                             0.5                               0.5                                                       Operating income      0.3                    15.5        3.0                    18.8    Other expense, net      0.2                    5.2                               5.4    Interest expense, net      0.1                    8.8        0.1                    9.0                                                       Income before income tax expense and equity income                             1.5        2.9                    4.4    Income tax expense                             1.8                               1.8    Equity income      1.3                    1.4                    (2.7 )                                                                Net income (loss)    $ 1.3      $           $ 1.1      $ 2.9       $ (2.7 )    $ 2.6    Less: Net income attributable to non-controlling interests                                        1.3                    1.3                                                       Net income (loss) attributed to Cott Corporation    $ 1.3      $           $ 1.1      $ 1.6       $ (2.7 )    $ 1.3                                                       Comprehensive (loss) income attributed to Cott Corporation    $ (14.6 )    $           $ (32.8 )    $ 3.2       $ 29.6      $ (14.6 )                                                     Condensed Consolidating Statements of Operations (in millions of U.S. dollars) Unaudited        For the Nine Months Ended September 27, 2014        Cott Corporation     DS Services of America, Inc.      DSS Guarantor Subsidiaries     DSS Non-Guarantor Subsidiaries      Elimination Entries     Consolidated   Revenue, net    $ 129.0      $           $ 1,363.9      $ 104.0       $ (37.6 )    $ 1,559.3    Cost of sales      111.4                    1,194.3        86.5         (37.6 )      1,354.6                                                       Gross profit      17.6                    169.6        17.5                    204.7    Selling, general and administrative expenses      18.3                    120.3        8.9                    147.5    Loss on disposal of property, plant   equipment      0.2                    0.2                               0.4    Restructuring      2.1                    0.3                               2.4    Asset impairments      0.9                    0.8                               1.7    Acquisition and integration expenses                             3.4                               3.4                                                       Operating (loss) income      (3.9 )                  44.6        8.6                    49.3    Other (income) expense, net      (9.1 )                  31.9        0.1                    22.9    Interest expense, net      0.2                    26.9        0.1                    27.2                                                       Income (loss) before income tax (benefit) expense and equity (loss) income      5.0                    (14.2 )      8.4                    (0.8 )  Income tax (benefit) expense      (1.4 )                  5.1        0.1                    3.8    Equity (loss) income      (15.1 )                  4.1                    11.0                                                                  Net (loss) income    $ (8.7 )    $           $ (15.2 )    $ 8.3       $ 11.0      $ (4.6 )  Less: Net income attributable to non-controlling interests                                        4.1                    4.1    Net (loss) income attributed to Cott Corporation    $ (8.7 )    $           $ (15.2 )    $ 4.2       $ 11.0      $ (8.7 )                                                     Comprehensive (loss) income attributed to Cott Corporation    $ (17.9 )    $           $ 6.9      $ 5.0       $ (11.9 )    $ (17.9 )                                                     Consolidating Balance Sheets (in millions of U.S. dollars) Unaudited        As of October 3, 2015        Cott Corporation     DS Services of America, Inc.     DSS Guarantor Subsidiaries     DSS Non-Guarantor Subsidiaries     Elimination Entries     Consolidated   ASSETS              Current assets              Cash   cash equivalents    $ 2.0      $ 20.6      $ 33.7      $ 7.4      $          $ 63.7    Accounts receivable, net of allowance      17.3        122.1        197.1        10.9        (23.0 )      324.4    Income taxes recoverable                 0.6        0.4        0.1                   1.1    Inventories      13.5        28.6        205.3        6.5                   253.9    Prepaid expenses and other assets      2.7        10.0        24.6        0.2                   37.5                                                     Total current assets      35.5        181.9        461.1        25.1        (23.0 )      680.6    Property, plant   equipment, net      31.3        397.9        367.2        6.8                   803.2    Goodwill      20.7        568.0        162.4                              751.1    Intangibles and other assets, net      0.9        396.0        336.0        3.7                   736.6    Deferred income taxes      2.7                   37.8        0.2        (37.8 )      2.9    Other tax receivable                            0.9                              0.9    Due from affiliates      411.4                   544.4                   (955.8 )             Investments in subsidiaries      193.6                   398.9                   (592.5 )                                                              Total assets    $ 696.1      $ 1,543.8      $ 2,308.7      $ 35.8      $ (1,609.1 )    $ 2,975.3                                                     LIABILITIES AND EQUITY              Current liabilities              Short-term borrowings    $          $          $ 152.0      $          $          $ 152.0    Current maturities of long-term debt                            3.1        0.6                   3.7    Accounts payable and accrued liabilities      36.6        126.6        286.1        9.9        (23.0 )      436.2                                                     Total current liabilities      36.6        126.6        441.2        10.5        (23.0 )      591.9    Long-term debt                 391.5        1,156.4                              1,547.9    Deferred income taxes                 112.8        20.3                   (37.8 )      95.3    Other long-term liabilities      0.5        34.7        41.0        1.2                   77.4    Due to affiliates      1.2        543.3        382.5        28.8        (955.8 )                                                              Total liabilities      38.3        1,208.9        2,041.4        40.5        (1,016.6 )      2,312.5    Equity              Capital stock, no par      532.6        355.6        702.8        38.5        (1,096.9 )      532.6    Additional paid-in-capital      53.0                                                    53.0    Retained earnings (deficit)      140.5        (20.8 )      (430.8 )      (56.6 )      508.2        140.5    Accumulated other comprehensive (loss) income      (68.3 )      0.1        (4.7 )      8.4        (3.8 )      (68.3 )                                                   Total Cott Corporation equity      657.8        334.9        267.3        (9.7 )      (592.5 )      657.8    Non-controlling interests                                       5.0                   5.0                                                     Total equity      657.8        334.9        267.3        (4.7 )      (592.5 )      662.8                                                             Total liabilities and equity    $ 696.1      $ 1,543.8      $ 2,308.7      $ 35.8      $ (1,609.1 )    $ 2,975.3                                                     Consolidating Balance Sheets (in millions of U.S. dollars)        As of January 3, 2015        Cott Corporation     DS Services of America, Inc.     DSS Guarantor Subsidiaries     DSS Non-Guarantor Subsidiaries     Elimination Entries     Consolidated   ASSETS              Current assets              Cash   cash equivalents    $ 6.2      $ 34.4      $ 38.2      $ 7.4      $          $ 86.2    Accounts receivable, net of allowance      16.2        105.4        358.8        12.2        (186.9 )      305.7    Income taxes recoverable                 0.6        0.6        0.4                   1.6    Inventories      12.4        34.2        210.3        5.5                   262.4    Prepaid expenses and other assets      3.2        10.3        45.4        0.4                   59.3                                                     Total current assets      38.0        184.9        653.3        25.9        (186.9 )      715.2    Property, plant   equipment, net      38.2        415.5        403.0        7.8                   864.5    Goodwill      23.4        556.9        163.3                              743.6    Intangibles and other assets, net      0.7        415.6        358.7        6.7                   781.7    Deferred income taxes      2.5                                                    2.5    Other tax receivable      0.1                   0.1                              0.2    Due from affiliates      183.8                   403.0        0.1        (586.9 )             Investments in subsidiaries      436.3                   973.1                   (1,409.4 )                                                              Total assets    $ 723.0      $ 1,572.9      $ 2,954.5      $ 40.5      $ (2,183.2 )    $ 3,107.7                                                     LIABILITIES, PREFERRED SHARES AND EQUITY              Current liabilities              Short-term borrowings    $          $          $ 229.0      $          $          $ 229.0    Current maturities of long-term debt      0.1                   3.0        0.9                   4.0    Accounts payable and accrued liabilities      30.4        106.8        461.9        8.1        (186.9 )      420.3                                                     Total current liabilities      30.5        106.8        693.9        9.0        (186.9 )      653.3    Long-term debt                 405.6        1,158.8        0.6                   1,565.0    Deferred income taxes                 129.3        (9.4 )                            119.9    Other long-term liabilities      0.4        29.6        40.5        1.3                   71.8    Due to affiliates      1.3        548.8        3.9        32.9        (586.9 )                                                              Total liabilities      32.2        1,220.1        1,887.7        43.8        (773.8 )      2,410.0    Convertible preferred shares      116.1                                                    116.1    Non-convertible preferred shares      32.7                                                    32.7    Equity              Capital stock, no par      388.3        355.5        1,766.0        39.7        (2,161.2 )      388.3    Additional paid-in-capital      46.6                                                    46.6    Retained earnings (deficit)      158.1        (2.8 )      (694.5 )      (55.1 )      752.4        158.1    Accumulated other comprehensive (loss) income      (51.0 )      0.1        (4.7 )      5.2        (0.6 )      (51.0 )                                                   Total Cott Corporation equity      542.0        352.8        1,066.8        (10.2 )      (1,409.4 )      542.0    Non-controlling interests                                       6.9                   6.9                                                     Total equity      542.0        352.8        1,066.8        (3.3 )      (1,409.4 )      548.9                                                     Total liabilities, preferred shares and equity    $ 723.0      $ 1,572.9      $ 2,954.5      $ 40.5      $ (2,183.2 )    $ 3,107.7                                                     Consolidating Statements of Condensed Cash Flows (in millions of U.S. dollars) Unaudited       For the Three Months Ended October 3, 2015       Cott Corporation     DS Services of America, Inc.     DSS Guarantor Subsidiaries     DSS Non-Guarantor Subsidiaries     Elimination Entries     Consolidated   Operating Activities             Net income (loss)   $ 4.8      $ (2.4 )    $ 7.3      $ 3.5      $ (6.8 )    $ 6.4    Depreciation   amortization     1.2        32.3        23.3        1.3                   58.1    Amortization of financing fees     0.1                   1.1                              1.2    Amortization of senior notes premium                (1.3 )                                       (1.3 )  Share-based compensation expense                0.6        1.7                              2.3    (Decrease) increase in deferred income taxes     (1.6 )      1.8        (4.9 )                            (4.7 )  Loss on disposal of property, plant   equipment                0.9        0.2                              1.1    Equity income, net of distributions     (5.8 )                 (1.0 )                 6.8               Intercompany dividends     0.2                   3.3                   (3.5 )             Other non-cash items     (3.1 )      (1.1 )      9.2        (0.3 )                 4.7    Net change in operating assets and liabilities, net of acquisition     (0.2 )      1.4        18.4        4.4                   24.0                                                    Net cash (used in) provided by operating activities     (4.4 )      32.2        58.6        8.9        (3.5 )      91.8                                                    Investing Activities             Acquisition, net of cash received                (22.0 )                                       (22.0 )  Additions to property, plant   equipment     (0.5 )      (18.5 )      (8.7 )      (0.6 )                 (28.3 )  Additions to intangibles and other assets                           (0.5 )                            (0.5 )  Proceeds from sale of property, plant   equipment                0.3        0.1                              0.4                                                    Net cash used in investing activities     (0.5 )      (40.2 )      (9.1 )      (0.6 )                 (50.4 )                                                  Financing Activities             Payments of long-term debt     (0.1 )                 (0.8 )      (0.1 )                 (1.0 )  Borrowings under ABL                           52.4                              52.4    Payments under ABL                           (97.3 )                            (97.3 )  Distributions to non-controlling interests                                      (3.2 )                 (3.2 )  Issuance of common shares     0.5                                                    0.5    Financing fees                           (0.1 )                            (0.1 )  Common shares repurchased and cancelled     (0.1 )                                                  (0.1 )  Dividends paid to common and preferred shareowners     (6.5 )                                                  (6.5 )  Intercompany dividends                           (0.2 )      (3.3 )      3.5                                                               Net cash used in financing activities     (6.2 )                 (46.0 )      (6.6 )      3.5        (55.3 )                                                  Effect of exchange rate changes on cash     (0.7 )                 (0.6 )      (0.1 )                 (1.4 )                                                  Net (decrease) increase in cash   cash equivalents     (11.8 )      (8.0 )      2.9        1.6                   (15.3 )                                                  Cash   cash equivalents, beginning of period     13.8        28.6        30.8        5.8                   79.0                                                    Cash   cash equivalents, end of period   $ 2.0      $ 20.6      $ 33.7      $ 7.4      $          $ 63.7                                                      Consolidating Statements of Condensed Cash Flows (in millions of U.S. dollars) Unaudited        For the Nine Months Ended October 3, 2015        Cott Corporation     DS Services of America, Inc.     DSS Guarantor Subsidiaries     DSS Non-Guarantor Subsidiaries     Elimination Entries     Consolidated   Operating Activities              Net income (loss)    $ 18.9      $ (18.0 )    $ 23.7      $ 10.1      $ (11.2 )    $ 23.5    Depreciation   amortization      3.6        94.3        71.7        4.1                   173.7    Amortization of financing fees      0.1                   3.5                              3.6    Amortization of senior notes premium                 (4.2 )                                       (4.2 )  Share-based compensation expense      1.2        1.7        5.4        0.1                   8.4    Decrease in deferred income taxes      (0.5 )      (10.8 )      (10.1 )      (0.2 )                 (21.6 )  Loss (gain) on disposal of property, plant   equipment                 2.9        (0.2 )                            2.7    Equity income, net of distributions      (7.2 )                 (4.0 )                 11.2               Intercompany dividends      4.5                   7.0                   (11.5 )             Other non-cash items      (9.9 )      (1.1 )      (0.5 )      (0.3 )                 (11.8 )  Net change in operating assets and liabilities, net of acquisition      18.6        (11.4 )      (17.0 )      1.9                   (7.9 )                                                   Net cash provided by operating activities      29.3        53.4        79.5        15.7        (11.5 )      166.4                                                     Investing Activities              Acquisition, net of cash received                 (22.5 )                                       (22.5 )  Additions to property, plant   equipment      (1.0 )      (57.3 )      (26.2 )      (1.0 )                 (85.5 )  Additions to intangibles and other assets                 (1.9 )      (0.8 )                            (2.7 )  Proceeds from sale of property, plant   equipment and sale-leaseback                 14.5        26.4                              40.9                                                     Net cash used in investing activities      (1.0 )      (67.2 )      (0.6 )      (1.0 )                 (69.8 )                                                   Financing Activities              Payments of long-term debt      (0.1 )                 (2.2 )      (0.6 )                 (2.9 )  Borrowings under ABL                            801.3                              801.3    Payments under ABL                            (874.5 )                            (874.5 )  Distributions to non-controlling interests                                       (6.8 )                 (6.8 )  Issuance of common shares      143.1                                                    143.1    Financing fees                            (0.3 )                            (0.3 )  Common shares repurchased and cancelled      (0.8 )                                                  (0.8 )  Preferred shares repurchased and cancelled      (148.8 )                                                  (148.8 )  Dividends paid to common and preferred shareowners      (24.5 )                                                  (24.5 )  Payment of deferred consideration for acquisitions                            (2.5 )                            (2.5 )  Intercompany dividends                            (4.5 )      (7.0 )      11.5                                                                Net cash used in financing activities      (31.1 )                 (82.7 )      (14.4 )      11.5        (116.7 )  Effect of exchange rate changes on cash      (1.4 )                 (0.7 )      (0.3 )                 (2.4 )                                                   Net decrease in cash   cash equivalents      (4.2 )      (13.8 )      (4.5 )                            (22.5 )                                                   Cash   cash equivalents, beginning of period      6.2        34.4        38.2        7.4                   86.2                                                     Cash   cash equivalents, end of period    $ 2.0      $ 20.6      $ 33.7      $ 7.4      $          $ 63.7                                                       Consolidating Statements of Condensed Cash Flows (in millions of U.S. dollars) Unaudited        For the Three Months Ended September 27, 2014        Cott Corporation     DS Services of America, Inc.      DSS Guarantor Subsidiaries     DSS Non-Guarantor Subsidiaries     Elimination Entries     Consolidated   Operating Activities               Net income (loss)    $ 1.3      $           $ 1.1      $ 2.9      $ (2.7 )    $ 2.6    Depreciation   amortization      1.7                    23.7        1.4                   26.8    Amortization of financing fees                             0.7                              0.7    Share-based compensation expense      0.1                    1.3        0.1                   1.5    (Decrease) increase in deferred income taxes      (0.3 )                  2.5                              2.2    Loss on disposal of property, plant   equipment      0.2                    0.2                              0.4    Asset impairments                             (0.2 )                            (0.2 )  Write off of financing fees and discount                             0.8                              0.8    Equity income, net of distributions      (1.3 )                  (1.4 )                 2.7               Intercompany dividends      44.2                    2.5                   (46.7 )             Other non-cash items      (0.2 )                  0.2                                     Net change in operating assets and liabilities      (36.6 )                  59.5        2.8                   25.7                                                      Net cash provided by operating activities      9.1                    90.9        7.2        (46.7 )      60.5                                                      Investing Activities               Additions to property, plant   equipment                             (10.4 )      (0.4 )                 (10.8 )  Additions to intangibles and other assets                             (1.5 )                            (1.5 )  Proceeds from sale of property, plant   equipment                             1.6                              1.6                                                      Net cash used in investing activities                             (10.3 )      (0.4 )                 (10.7 )                                                    Financing Activities               Payments of long-term debt                             (79.3 )      (0.8 )                 (80.1 )  Borrowings under ABL                             191.1                              191.1    Payments under ABL                             (156.0 )                            (156.0 )  Distributions to non-controlling interests                                        (2.4 )                 (2.4 )  Financing fees                             (1.2 )                            (1.2 )  Common shares repurchased and cancelled      (4.6 )                                                   (4.6 )  Payment of deferred consideration for acquisitions                             (32.4 )                            (32.4 )  Dividends paid to common shareholders      (5.6 )                                                   (5.6 )  Intercompany dividends                             (44.2 )      (2.5 )      46.7                                                                 Net cash used in financing activities      (10.2 )                  (122.0 )      (5.7 )      46.7        (91.2 )  Effect of exchange rate changes on cash      (0.4 )                  (1.6 )      (0.1 )                 (2.1 )                                                    Net (decrease) increase in cash   cash equivalents      (1.5 )                  (43.0 )      1.0                   (43.5 )                                                    Cash   cash equivalents, beginning of period      7.2                    77.0        6.7                   90.9                                                      Cash   cash equivalents, end of period    $ 5.7      $           $ 34.0      $ 7.7      $          $ 47.4                                                        Consolidating Statements of Condensed Cash Flows (in millions of U.S. dollars) Unaudited        For the Nine Months Ended September 27, 2014        Cott Corporation     DS Services of America, Inc.      DSS Guarantor Subsidiaries     DSS Non-Guarantor Subsidiaries     Elimination Entries     Consolidated   Operating Activities               Net (loss) income    $ (8.7 )    $           $ (15.2 )    $ 8.3      $ 11.0      $ (4.6 )  Depreciation   amortization      4.8                    68.6        4.3                   77.7    Amortization of financing fees      0.1                    1.8                              1.9    Share-based compensation expense      0.9                    3.9        0.1                   4.9    (Decrease) increase in deferred income taxes      (1.6 )                  5.7                              4.1    Loss on disposal of property, plant   equipment      0.2                    0.2                              0.4    Asset impairments      0.9                    0.8                              1.7    Write off of financing fees and discount                             4.1                              4.1    Equity loss (income), net of distributions      15.1                    (4.1 )                 (11.0 )             Intercompany dividends      62.4                    7.5                   (69.9 )             Other non-cash items      (0.4 )                  (0.3 )                            (0.7 )  Net change in operating assets and liabilities      (44.3 )                  (13.2 )      5.5                   (52.0 )                                                    Net cash provided by operating activities      29.4                    59.8        18.2        (69.9 )      37.5                                                      Investing Activities               Acquisitions, net of cash received                             (80.8 )                            (80.8 )  Additions to property, plant   equipment      (0.9 )                  (30.1 )      (0.4 )                 (31.4 )  Additions to intangibles and other assets                             (4.3 )                            (4.3 )  Proceeds from sale of property, plant   equipment                             1.6                              1.6                                                      Net cash used in investing activities      (0.9 )                  (113.6 )      (0.4 )                 (114.9 )                                                    Financing Activities               Payments of long-term debt      (0.1 )                  (391.7 )      (0.8 )                 (392.6 )  Issue of long-term debt                             525.0                              525.0    Borrowings under ABL                             474.3                              474.3    Payments under ABL                             (455.4 )                            (455.4 )  Distributions to non-controlling interests                                        (7.2 )                 (7.2 )  Financing fees                             (9.1 )                            (9.1 )  Common shares repurchased and cancelled      (7.7 )                                                   (7.7 )  Payment of deferred consideration for acquisitions                             (32.4 )                            (32.4 )  Dividends paid to common shareholders      (16.4 )                                                   (16.4 )  Intercompany dividends                             (62.4 )      (7.5 )      69.9                                                                 Net cash (used in) provided by financing activities      (24.2 )                  48.3        (15.5 )      69.9        78.5    Effect of exchange rate changes on cash      (0.1 )                  (0.7 )      (0.1 )                 (0.9 )                                                    Net increase (decrease) in cash   cash equivalents      4.2                    (6.2 )      2.2                   0.2                                                      Cash   cash equivalents, beginning of period      1.5                    40.2        5.5                   47.2                                                      Cash   cash equivalents, end of period    $ 5.7      $           $ 34.0      $ 7.7      $          $ 47.4                                                        The 2022 Notes and 2020 Notes, each issued by our 100% owned subsidiary, CBI, are guaranteed on a senior secured basis pursuant to guarantees by Cott Corporation and certain other 100% owned direct and indirect subsidiaries (the &#x201C;Cott Guarantor Subsidiaries&#x201D;)."
26,q4-15,10-Q,LIGHTING SCIENCE GROUP CORP,866970,2015-11-13,http://www.sec.gov/Archives/edgar/data/866970/000143774915020780,No,"For the nine months ended October 3, 2015, sales to Walmart accounted for 18.1% (September 27, 2014 26.4%) of our total revenue, 32.9% of our North America reporting segment revenue (September 27, 2014 32.5%), 11.8% of our U.K. reporting segment revenue (September 27, 2014 12.9%), 4.1% of our All Other reporting segment revenue (September 27, 2014 3.1%), and 2.2% of our DSS reporting segment revenue."
27,q4-15,10-Q,LIGHTING SCIENCE GROUP CORP,866970,2015-11-13,http://www.sec.gov/Archives/edgar/data/866970/000143774915020780,No,"Risk and Uncertainties: In fiscal 2015, one class of similar products accounted for approximately 11 percent of the Company s total revenues, and one vendor supplied approximately 11 percent of the Company s total purchases."
28,q4-15,10-Q/A,SUNPOWER CORP,867773,2015-10-29,http://www.sec.gov/Archives/edgar/data/867773/000086777315000074,No," LEGG MASON PARTNERS EQUITY TRUST SUPPLEMENT DATED NOVEMBER 4, 2015 TO THE SUMMARY PROSPECTUS AND PROSPECTUS OF PERMAL ALTERNATIVE CORE FUND, DATED MAY 1, 2015     Effective February 1, 2016, the following replaces the fee table and footnotes and expense example in the section of the fund s Summary Prospectus and Prospectus titled  Fees and expenses of the fund  in order to disclose the expense limitation for Class A, Class C, Class FI, Class R, Class I and Class IS shares of the fund resulting from the exclusion of  Acquired Fund Fees and Expenses  from such expense limitations:   Shareholder fees     (fees paid directly from your investment)                 Class A   Class C   Class FI   Class R   Class I   Class IS Maximum sales charge (load) imposed on purchases (as a % of offering price)   5.75   None   None   None   None   None Maximum deferred sales charge (load) (as a % of the lower of net asset value at purchase or redemption) 1   None 2   1.00   None   None   None   None Small account fee 3   $15   $15   None   None   None   None                         Annual fund operating expenses (%)                     (expenses that you pay each year as a percentage of the value of your investment)     Class A   Class C   Class FI   Class R   Class I   Class IS Management fees   0.65   0.65   0.65   0.65   0.65   0.65 Distribution and/or service (12b-1) fees   0.25   1.00   0.25   0.50   None   None Other expenses   0.50   0.49   0.79   0.55 4   0.48   0.72 Acquired fund fees and expenses (fees and expenses of underlying funds)   1.30   1.30   1.30   1.30   1.30   1.30 Total annual fund operating expenses 5   2.70   3.44   2.99   3.00   2.43   2.67 Fees waived and/or expenses reimbursed 6   (0.25)   (0.24)   (0.54)   (0.30)   (0.23)   (0.47) Total annual fund operating expenses after waiving fees and/or reimbursing expenses   2.45   3.20   2.45   2.70   2.20   2.20     1   Maximum deferred sales charge (load) may be reduced over time."
29,q4-15,10-Q/A,SUNPOWER CORP,867773,2015-10-29,http://www.sec.gov/Archives/edgar/data/867773/000086777315000074,No," Revenue Recognition   The majority of the Company s revenues are comprised of: 1) transaction-based fees, which typically constitute a percentage of dollar volume processed; 2) fees per transaction processed; 3) fees per account on file during the period; or 4) some combination thereof."
30,q4-15,10-K,"PRECISION OPTICS CORPORATION, INC.",867840,2015-10-13,http://www.sec.gov/Archives/edgar/data/867840/000101968715003701,No,"There were no customers with balances greater than 10% of accounts receivable as of September 26, 2015 and September 27, 2014 , or any customers that represented greater than 10% of consolidated revenues for fiscal years 2015 , 2014 and 2013 ."
31,q4-15,10-K,"PRECISION OPTICS CORPORATION, INC.",867840,2015-10-13,http://www.sec.gov/Archives/edgar/data/867840/000101968715003701,No,"Revenues by geographic area were as follows (in thousands):   Three Months Ended   Nine Months Ended   September 30,   September 30,   2015   2014   2015   2014 United States $ 18,353   $ 17,476   $ 57,997   $ 52,207 Other North America 186   254   473   1,957 China 5,859   7,172   26,414   22,152 India 6,549   5,878   12,494   7,505 Other Asia Pacific 6,798   8,253   19,108   24,741 Asia Pacific (""APAC"") 19,206   21,303   58,016   54,398 Netherlands 3,404   7,861   10,591   19,030 Other EMEA 3,631   3,911   13,439   16,976 Europe, the Middle East and Africa ( EMEA ) 7,035   11,772   24,030   36,006 Foreign Countries 26,427   33,329   82,519   92,361 Total $ 44,780   $ 50,805   $ 140,516   $ 144,568 Long-lived assets by geographic area are as follows (in thousands):   September 30, 2015   December 31, 2014 Property and equipment, net       United States $ 3,381 $ 4,558 Other North America 308 672 China 1,447   2,427 Other APAC     11 Total APAC 1,447   2,438 India 1,690   2,115 Other EMEA 2   3 Total EMEA 1,692 2,118 Foreign Countries 3,447   5,228 Total property and equipment, net $ 6,828   $ 9,786         Intangible assets, net       United States $ 33,509   $ 43,224 Total intangible assets, net $ 33,509   $ 43,224 The following customers accounted for more than 10% of the Company's total revenues:         Three Months Ended   Nine Months Ended   September 30,   September 30,   2015   2014   2015   2014 Nokia Networks 14.1 %   13.0 %   19.5 %   16.5 % Philips Healthcare N/A   18.7 %   N/A   16.4 % An Asian Carrier 14.2 %   10.6 %   N/A   N/A The following customers accounted for more than 10% of accounts receivable:         September 30, 2015   December 31, 2014 Nokia Networks N/A   18.5 % Philips Healthcare N/A   13.9 % An Asian Carrier 25.7 %   N/A Sanmina SCI Corp (A) 10.0 %   N/A "
32,q4-15,10-Q,"ProPhase Labs, Inc.",868278,2015-11-13,http://www.sec.gov/Archives/edgar/data/868278/000149315215005401,No,"During the six months ended September 30, 2014, one distributor in the United States, MWI Veterinary Supply, accounted for 18% of our total worldwide revenues."
33,q4-15,10-K,SONIC CORP,868611,2015-10-23,http://www.sec.gov/Archives/edgar/data/868611/000086861115000057,No,No other single customer accounted for more than 10 percent of unit sales during those periods.
34,q4-15,10-K,AECOM,868857,2015-11-25,http://www.sec.gov/Archives/edgar/data/868857/000104746915008965,No,"Significant assumptions used to determine fair value based on significant unobservable inputs were as follows:     September 30, 2015   Dec. 31, 2014   September 30, 2014 Discount rate   risk-free rate plus a market premium   10.12%   10.17%   10.17% Loan servicing costs   annually per loan based upon loan type:                 Performing loans   $63-$105   $60 - $105   $60 - $105     Delinquent loans   $150 - $500   $150 - $500   $150 - $500     Loans in foreclosure   $650 - $4,250   $1,000 - $4,250   $1000 - $4,250 Escrow earnings rate   indexed to rates paid on deposit accounts with comparable average life   1.40%   1.77%   1.95% The Company is exposed to interest rate risk as benchmark residential mortgage interest rates directly affect the prepayment speeds used in valuing our mortgage servicing rights, which is partially managed through forward sales of residential mortgage-backed securities and forward sales contracts."
35,q4-15,10-K,AECOM,868857,2015-11-25,http://www.sec.gov/Archives/edgar/data/868857/000104746915008965,No,"The CSO2015 transactions represented a call spread overlay with respect to the 4.50% debentures due 2015, whereby the cost of the 4.50% Bond Hedge purchased by the Company to cover the cash outlay upon conversion of the debentures is reduced by the sales prices of the 4.50% Warrants."
36,q4-15,10-K,AECOM,868857,2015-11-25,http://www.sec.gov/Archives/edgar/data/868857/000104746915008965,No,"Significant estimates include, among others, percentage-of-completion estimates for revenue and cost of sales recognition, incentive compensation and commissions, allowance for doubtful accounts receivable, inventory valuation reserves, warranty reserves, deferred tax valuation allowance, purchase price allocations on business acquisitions, fair value estimates of interest rate swap contracts and any impairment charges on long-lived assets and goodwill.  "
37,q4-15,10-Q,"Neonode, Inc",87050,2015-11-09,http://www.sec.gov/Archives/edgar/data/87050/000121390015008307,No,"For the three and nine-months ended September 30, 2014, one customer accounted for 10% and 11% of the Company s consolidated sales, respectively."
38,q4-15,10-Q,"Neonode, Inc",87050,2015-11-09,http://www.sec.gov/Archives/edgar/data/87050/000121390015008307,No,"During the year ended December 31, 2013, three customers accounted for 100% of the Company s revenue."
39,q4-15,10-Q,"Neonode, Inc",87050,2015-11-09,http://www.sec.gov/Archives/edgar/data/87050/000121390015008307,No,"During the nine months ended September 30, 2014, three customers accounted for 94% of the Company s revenue."
40,q4-15,10-Q,"Neonode, Inc",87050,2015-11-09,http://www.sec.gov/Archives/edgar/data/87050/000121390015008307,No,"For the three and nine-months ended September 30, 2015, 0 customer accounted for 10% or more of the Company s consolidated sales."
41,q4-15,10-Q,ATMEL CORP,872448,2015-10-30,http://www.sec.gov/Archives/edgar/data/872448/000087244815000032,No,"Concentrations of Credit Risk   For the three months ended September 30, 2015 and 2014, revenue derived from sales to The Home Depot represented 89% and 82%, respectively, of the Company s total revenue."
42,q4-15,10-Q,ATMEL CORP,872448,2015-10-30,http://www.sec.gov/Archives/edgar/data/872448/000087244815000032,No," Two customers, HP Enterprise Services ( HP ) and International Business Machines Corp. ( IBM ) accounted for a significant portion of the Company s revenues for the respective three and nine month periods ended September 30, 2015 and 2014 as follows:       For the three months ended     For the nine months ended       2015     2014     2015     2014   HP Customer A     15.7 %     14.8 %     14.7 %     14.5 % HP Customer B     11.7 %     11.9 %     11.8 %     14.3 % HP Customer C     6.6 %     6.5 %     6.3 %     8.5 % Total HP     34.0 %     33.2 %     32.8 %     37.3 % IBM     36.4 %     44.3 %     37.8 %     39.3 % Total major customers     70.4 %     77.5 %     70.6 %     76.6 % Others     29.6 %     22.5 %     29.4 %     23.4 % Total     100.0 %     100.0 %     100.0 %     100.0 % "
43,q4-15,10-Q,ATMEL CORP,872448,2015-10-30,http://www.sec.gov/Archives/edgar/data/872448/000087244815000032,No,"One customer, in the aggregate, accounted for 12.8% , 10.5% , and 11.3% of the Company s consolidated revenue in fiscal 2015 , 2014 and 2013 , respectively. "
44,q4-15,10-Q,ATMEL CORP,872448,2015-10-30,http://www.sec.gov/Archives/edgar/data/872448/000087244815000032,No,"patents license agreements, which currently account for 88% of our year to date revenue."
45,q4-15,10-Q,ATMEL CORP,872448,2015-10-30,http://www.sec.gov/Archives/edgar/data/872448/000087244815000032,No,"                   Midstream   Marketing   UGI International       Total   Elim- inations   AmeriGas Propane   Gas Utility   Energy Services   Electric Generation   UGI France   Flaga   Other   Corporate   Other (b) 2015                                   Revenues $ 6,691.1   $ (232.6 ) (c) $ 2,885.3   $ 933.1   $ 1,041.8   $ 75.9   $ 1,122.2   $ 686.3   $ 179.1 Cost of sales $ 3,736.5   $ (228.8 ) (c) $ 1,340.0   $ 448.6   $ 800.9   $ 32.2   $ 628.0   $ 492.0   $ 223.6 Operating income (loss) $ 834.9   $ (0.9 )   $ 427.6   $ 226.5   $ 171.8   $ 13.0   $ 75.9   $ 36.9   $ (115.9 ) Loss from equity investees (1.2 )                       (1.2 )         Interest expense (241.9 )       (162.8 )   (39.1 )   (2.1 )       (31.6 ) (d) (3.6 )   (2.7 ) Income (loss) before income taxes $ 591.8   $ (0.9 )   $ 264.8   $ 187.4   $ 169.7   $ 13.0   $ 43.1   $ 33.3   $ (118.6 ) Net income (loss) attributable to UGI $ 281.0   $ (0.6 )   $ 61.0   $ 115.8   $ 99.3   $ 9.6   $ 27.5   $ 25.2   $ (56.8 ) Depreciation and amortization $ 374.1   $     $ 194.9   $ 59.0   $ 14.6   $ 12.5   $ 63.7   $ 23.2   $ 6.2 Noncontrolling interests  net income (loss) $ 133.0   $     $ 167.9   $     $     $     $     $ (0.1 )   $ (34.8 ) Partnership Adjusted EBITDA (a)       $ 619.2                                           Midstream   Marketing   UGI International       Total   Elim- inations   AmeriGas Propane   Gas Utility   Energy Services   Electric Generation   UGI France   Flaga   Other   Corporate   Other (b) Total assets $ 10,546.6   $ (90.4 )   $ 4,150.0   $ 2,362.4   $ 664.3   $ 282.0   $ 2,340.4   $ 529.1   $ 308.8 Short-term borrowings $ 189.9   $     $ 68.1   $ 71.7   $ 49.5   $     $ 0.1   $ 0.5   $   Capital expenditures $ 475.4   $     $ 102.0   $ 189.7   $ 71.5   $ 16.7   $ 65.0   $ 22.5   $ 8.0 Investments in equity investees $ 16.2   $     $     $     $ 6.4   $     $ 6.0   $ 3.8   $   Goodwill $ 2,953.4   $     $ 1,956.0   $ 182.1   $ 5.6   $     $ 721.4   $ 82.3   $ 6.0                                     2014                                   Revenues $ 8,277.3   $ (321.3 ) (c) $ 3,712.9   $ 977.3   $ 1,305.5   $ 85.1   $ 1,295.5   $ 1,026.9   $ 195.4 Cost of sales $ 5,175.7   $ (317.7 ) (c) $ 2,107.1   $ 496.8   $ 1,058.8   $ 39.6   $ 848.1   $ 809.9   $ 133.1 Operating income (loss) $ 1,005.6   $ 0.2   $ 472.0   $ 236.2   $ 180.5   $ 18.1   $ 79.1   $ 38.4   $ (18.9 ) Loss from equity investees (0.1 )                       (0.1 )         Interest expense (237.7 )       (165.6 )   (36.6 )   (2.9 )       (25.1 )   (4.9 )   (2.6 ) Income (loss) before income taxes 767.8   0.2   306.4   199.6   177.6   18.1   53.9   33.5   (21.5 ) Net income (loss) attributable to UGI $ 337.2   $     $ 63.0   $ 118.8   $ 105.2   $ 12.6   $ 20.6   $ 27.7   $ (10.7 ) Depreciation and amortization $ 362.9   $     $ 197.2   $ 54.8   $ 12.3   $ 10.7   $ 54.5   $ 27.1   $ 6.3 Noncontrolling interests  net income (loss) $ 195.4   $     $ 195.8   $     $     $     $ (0.4 )   $     $   Partnership Adjusted EBITDA (a)       $ 664.8                         Total assets $ 10,093.0   $ (86.5 )   $ 4,377.0   $ 2,214.1   $ 569.0   $ 277.7   $ 1,659.1   $ 643.6   $ 439.0 Short-term borrowings $ 210.8   $     $ 109.0   $ 86.3   $ 7.5   $     $     $ 8.0   $   Capital expenditures $ 436.4   $     $ 113.9   $ 156.4   $ 67.8   $ 15.6   $ 50.2   $ 23.0   $ 9.5 Investments in equity investees $ 0.6   $     $     $     $     $     $     $ 0.6   $   Goodwill $ 2,833.4   $     $ 1,945.1   $ 182.1   $ 5.6   $     $ 601.2   $ 92.4   $ 7.0                                     2013                                   Revenues $ 7,194.7   $ (223.8 ) (c) $ 3,168.8   $ 839.0   $ 969.4   $ 71.4   $ 1,322.6   $ 856.6   $ 190.7 Cost of sales $ 4,324.4   $ (217.5 ) (c) $ 1,657.2   $ 407.2   $ 836.9   $ 39.9   $ 845.0   $ 653.4   $ 102.3 Operating income $ 831.1   $ (1.1 )   $ 394.4   $ 196.5   $ 82.5   $ 7.5   $ 111.4   $ 35.6   $ 4.3 Loss from equity investees (0.4 )                       (0.4 )         Interest expense (240.3 )       (166.6 )   (37.4 )   (3.2 )       (25.3 )   (5.1 )   (2.7 ) Income before income taxes $ 590.4   $ (1.1 )   $ 227.8   $ 159.1   $ 79.3   $ 7.5   $ 85.7   $ 30.5   $ 1.6 Net income attributable to UGI $ 278.1   $ (0.6 )   $ 47.5   $ 94.3   $ 46.3   $ 6.2   $ 57.2   $ 25.5   $ 1.7 Depreciation and amortization $ 363.1   $     $ 205.9   $ 51.7   $ 7.6   $ 10.0   $ 57.6   $ 24.1   $ 6.2 Noncontrolling interests  net income (loss) $ 149.5   $     $ 149.6   $     $     $     $ (0.2 )   $ 0.1   $   Partnership Adjusted EBITDA (a)         $ 596.5                         Total assets $ 10,008.8   $ (100.3 )   $ 4,429.3   $ 2,069.0   $ 501.2   $ 269.7   $ 1,784.4   $ 667.1   $ 388.4 Short-term borrowings $ 227.9   $     $ 116.9   $ 17.5   $ 87.0   $     $     $ 6.5   $   Capital expenditures $ 488.0   $ (1.1 )   $ 111.1   $ 144.4   $ 133.8   $ 22.6   $ 53.4   $ 17.4   $ 6.4 Investments in equity investees $ 0.3   $     $     $     $     $     $     $ 0.3   $   Goodwill $ 2,873.7   $     $ 1,941.0   $ 182.1   $ 2.8   $     $ 643.7   $ 97.1   $ 7.0 (a) The following table provides a reconciliation of Partnership Adjusted EBITDA to AmeriGas Propane operating income:     2015   2014   2013 Partnership Adjusted EBITDA   $ 619.2   $ 664.8   $ 596.5 Depreciation and amortization   (194.9 )   (197.2 )   (205.9 ) Noncontrolling interests (i)   3.3   4.4   3.8 Operating income   $ 427.6   $ 472.0   $ 394.4 (i) Principally represents the General Partner s 1.01% interest in AmeriGas OLP."
46,q4-15,10-Q,RADISYS CORP,873044,2015-10-30,http://www.sec.gov/Archives/edgar/data/873044/000087304415000130,No,"No other class of similar products accounted for 10 percent or more of total revenues, and no other individual vendor provided more than 10 percent of total purchases."
47,q4-15,10-Q,RADISYS CORP,873044,2015-10-30,http://www.sec.gov/Archives/edgar/data/873044/000087304415000130,No,"The following tables set forth summarized financial information concerning the Company's reportable segments:                                                                                                                                                                                      Reportable Segments:   Design and Consulting Services   Construction Services   Management Services   Corporate   Total   Fiscal Year Ended September 30, 2015:                                 Revenue   $ 7,962.9   $ 6,676.7   $ 3,350.3   $     $ 17,989.9   Cost of revenue     7,663.6     6,633.9     3,157.2           17,454.7   Gross profit     299.3     42.8     193.1           535.2   Equity in earnings of joint ventures     6.6     23.0     76.6           106.2   General and administrative expenses                       (114.0 )   (114.0 ) Acquisition and integration expenses                       (398.4 )   (398.4 ) Operating income (loss)     305.9     65.8     269.7     (512.4 )   129.0   Segment assets     7,118.2     3,382.4     2,903.9     609.8     14,014.3   Gross profit as a % of revenue     3.8 %   0.6 %   5.8 %         3.0 % Fiscal Year Ended September 30, 2014:                                 Revenue   $ 5,443.1   $ 2,004.3   $ 909.4   $     $ 8,356.8   Cost of revenue     5,112.8     1,975.0     865.8           7,953.6   Gross profit     330.3     29.3     43.6           403.2   Equity in earnings of joint ventures     35.5     6.0     16.4           57.9   General and administrative expenses                       (80.9 )   (80.9 ) Acquisition and integration expenses                       (27.3 )   (27.3 ) Operating income (loss)     365.8     35.3     60.0     (108.2 )   352.9   Segment assets     4,064.5     1,256.4     437.5     365.0     6,123.4   Gross profit as a % of revenue     6.1 %   1.5 %   4.8 %         4.8 % Fiscal Year Ended September 30, 2013:                                 Revenue   $ 5,556.1   $ 1,552.1   $ 1,045.3         $ 8,153.5   Cost of revenue     5,174.4     1,527.9     1,001.2           7,703.5   Gross profit     381.7     24.2     44.1           450.0   Equity in earnings of joint ventures     8.3     4.0     12.0           24.3   General and administrative expenses                       (97.3 )   (97.3 ) Operating income (loss)     390.0     28.2     56.1     (97.3 )   377.0   Segment assets     1,945.9     1,183.4     2,296.2     240.1     5,665.6   Gross profit as a % of revenue     6.9 %   1.6 %   4.2 %         5.5 % Geographic Information:                                                                                                                                                                                          Fiscal Year Ended       September 30, 2015   September 30, 2014   September 30, 2013       Revenue   Long-Lived Assets   Revenue   Long-Lived Assets   Revenue   Long-Lived Assets       (in millions)   United States   $ 12,599.6      4,852.5    $ 4,933.7      1,603.7    $ 4,829.6      1,477.3    Asia Pacific     1,385.3      426.4      1,338.2      340.5      1,507.2      361.0    Canada     1,308.3      641.0      561.1      146.7      712.0      168.4    Europe     1,796.9      1,496.2      788.2      270.8      599.4      267.2    Other foreign countries     899.8      352.1      735.6      209.5      505.3      116.6    &#x200B; &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; Total   $ 17,989.9      7,768.2    $ 8,356.8      2,571.2    $ 8,153.5      2,390.5    &#x200B; &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B; &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B; &#x200B;   &#x200B;   &#x200B;         The Company attributes revenue by geography based on the external customer's country of origin."
48,q4-15,10-Q,ISIS PHARMACEUTICALS INC,874015,2015-11-09,http://www.sec.gov/Archives/edgar/data/874015/000087401515000082,No,"During the three and nine months ended September 30, 2015, we earned revenue of $18.1 million and $75.1 million, respectively, from our relationship with Biogen, which represented 37 percent and 32 percent, respectively, of our total revenue for those periods."
49,q4-15,10-Q,ISIS PHARMACEUTICALS INC,874015,2015-11-09,http://www.sec.gov/Archives/edgar/data/874015/000087401515000082,No,"Under the Company s franchise agreements, both Company Drive-Ins and Franchise Drive-Ins must contribute a minimum percentage of revenues to a national media production fund (&#x201C;Sonic Brand Fund&#x201D;) and spend an additional minimum percentage of gross revenues on advertising, either directly or through Company-required participation in advertising cooperatives."
50,q4-15,10-Q,ISIS PHARMACEUTICALS INC,874015,2015-11-09,http://www.sec.gov/Archives/edgar/data/874015/000087401515000082,No,"During the six months ended September 30, 2015 and 2014 , The News Group accounted for approximately 26% and 21% , respectively, of our total operating revenues and The Hudson Group accounted for approximately 6% and 5% , respectively, of our total operating revenues."
51,q4-15,10-Q,ISIS PHARMACEUTICALS INC,874015,2015-11-09,http://www.sec.gov/Archives/edgar/data/874015/000087401515000082,No,"The Company had no customer in 2015, 2014 or 2013 that contributed in excess of 10% of the total net sales."
52,q4-15,10-K,ADDVANTAGE TECHNOLOGIES GROUP INC,874292,2015-12-15,http://www.sec.gov/Archives/edgar/data/874292/000144526015000049,No, We have historically funded our operations from collaborations with corporate partners and a relatively small number of partners have accounted for a significant percentage of our revenue.
53,q4-15,10-Q,"LIFETIME BRANDS, INC",874396,2015-11-06,http://www.sec.gov/Archives/edgar/data/874396/000119312515370120,No,"Fair Value of Financial Instruments The following table presents the carrying values and estimated fair values of all financial instruments, including those financial assets and liabilities that are not measured and reported at fair value on a recurring basis or non-recurring basis as of September 30, 2015 (dollars in thousands):     Carrying Value   Range of Contractual Yields   Average Re-pricing (in years)   Discount Rate   Estimated Fair Value Cash and due from banks   $ 489,268               $ 489,268 Interest-bearing cash and cash equivalents   1,830,105               1,830,105 Trading securities:                     U.S. Government agency debentures   42,431               42,431 U.S. agency residential mortgage-backed securities   30,973               30,973 Municipal and other tax-exempt securities   84,261               84,261 Other trading securities   23,466               23,466 Total trading securities   181,131               181,131 Investment securities:                     Municipal and other tax-exempt   379,980               384,310 U.S. agency residential mortgage-backed securities   28,653               30,080 Other debt securities   203,751               228,701 Total investment securities   612,384               643,091 Available for sale securities:                     U.S. Treasury   1,003               1,003 Municipal and other tax-exempt   57,960               57,960 U.S. agency residential mortgage-backed securities   5,819,127               5,819,127 Privately issued residential mortgage-backed securities   145,682               145,682 Commercial mortgage-backed securities guaranteed by U.S. government agencies   2,735,787               2,735,787 Other debt securities   4,150               4,150 Perpetual preferred stock   19,163               19,163 Equity securities and mutual funds   18,217               18,217 Total available for sale securities   8,801,089               8,801,089 Fair value option securities:                     U.S. agency residential mortgage-backed securities   427,760               427,760       Other securities                     Total fair value option securities   427,760               427,760 Residential mortgage loans held for sale   357,414               357,414 Loans:                     Commercial   9,797,422   0.19% - 30.00%   0.63   0.47% - 4.06%   9,530,437 Commercial real estate   3,235,067   0.38% - 18.00%   0.77   0.92% - 3.60%   3,330,298 Residential mortgage   1,868,995   1.25% - 18.00%   2.34   0.86% - 3.94%   1,906,585 Personal   465,957   0.38% - 21.00%   0.40   0.89% - 3.86%   462,266 Total loans   15,367,441               15,229,586 Allowance for loan losses   (204,116 )                 Loans, net of allowance   15,163,325               15,229,586 Mortgage servicing rights   200,049               200,049 Derivative instruments with positive fair value, net of cash margin   726,159               726,159 Other assets   private equity funds   24,133               24,133 Deposits with no stated maturity   18,120,912               18,120,912 Time deposits   2,498,531   0.02% - 9.64%   1.75   0.85% - 1.25%   2,500,469 Other borrowed funds   5,253,124   0.25% - 3.34%   0.02   0.07% - 2.66%   5,239,400 Subordinated debentures   226,314   1.01 %   1.63   1.83 %   223,334 Derivative instruments with negative fair value, net of cash margin   636,115               636,115 The following table presents the carrying values and estimated fair values of all financial instruments, including those financial assets and liabilities that are not measured and reported at fair value on a recurring basis or non-recurring basis as of December 31, 2014 (dollars in thousands):     Carrying Value   Range of Contractual Yields   Average Re-pricing (in years)   Discount Rate   Estimated Fair Value Cash and due from banks   $ 550,576               $ 550,576 Interest-bearing cash and cash equivalents   1,925,266               1,925,266 Trading securities:                     U.S. Government agency debentures   85,092               85,092 U.S. agency residential mortgage-backed securities   31,199               31,199 Municipal and other tax-exempt securities   38,951               38,951 Other trading securities   33,458               33,458 Total trading securities   188,700               188,700 Investment securities:                     Municipal and other tax-exempt   405,090               408,344 U.S. agency residential mortgage-backed securities   35,750               37,463 Other debt securities   211,520               227,819 Total investment securities   652,360               673,626 Available for sale securities:                     U.S. Treasury   1,005               1,005 Municipal and other tax-exempt   63,557               63,557 U.S. agency residential mortgage-backed securities   6,646,884               6,646,884 Privately issued residential mortgage-backed securities   165,957               165,957 Commercial mortgage-backed securities guaranteed by U.S. government agencies   2,048,609               2,048,609 Other debt securities   9,212               9,212 Perpetual preferred stock   24,277               24,277 Equity securities and mutual funds   19,444               19,444 Total available for sale securities   8,978,945               8,978,945 Fair value option securities:                     U.S. agency residential mortgage-backed securities   311,597               311,597       Other securities                     Total fair value option securities   311,597               311,597 Residential mortgage loans held for sale   304,182               304,182 Loans:                     Commercial   9,095,670   0.17% - 30.00%   0.65   0.51% - 4.34%   8,948,870 Commercial real estate   2,728,150   0.38% - 18.00%   0.84   1.09% - 3.78%   2,704,454 Residential mortgage   1,949,512   1.20% - 18.00%   2.50   0.64% - 3.99%   1,985,870 Personal   434,705   0.38% - 21.00%   0.45   1.04% - 3.98%   431,274 Total loans   14,208,037               14,070,468 Allowance for loan losses   (189,056 )                 Loans, net of allowance   14,018,981               14,070,468 Mortgage servicing rights   171,976               171,976 Derivative instruments with positive fair value, net of cash margin   361,874               361,874 Other assets   private equity funds   25,627               25,627 Deposits with no stated maturity   18,532,143               18,532,143 Time deposits   2,608,716   0.02% - 9.64%   1.92   0.76% - 1.33%   2,612,576 Other borrowed funds   3,378,294   0.21% - 1.52%   0.12   0.06% - 2.64%   3,331,771 Subordinated debentures   347,983   0.92% - 5.00%   1.67   2.14 %   344,687 Derivative instruments with negative fair value, net of cash margin   354,554               354,554 The following table presents the carrying values and estimated fair values of all financial instruments, including those financial assets and liabilities that are not measured and reported at fair value on a recurring basis or non-recurring basis as of September 30, 2014 (dollars in thousands):     Carrying Value   Range of Contractual Yields   Average Re-pricing (in years)   Discount Rate   Estimated Fair Value Cash and due from banks   $ 557,658               $ 557,658 Interest-bearing cash and cash equivalents   2,007,901               2,007,901 Trading securities:                     U.S. Government agency debentures   41,004               41,004 U.S. agency residential mortgage-backed securities   33,226               33,226 Municipal and other tax-exempt securities   76,884               76,884 Other trading securities   18,598               18,598 Total trading securities   169,712               169,712 Investment securities:                     Municipal and other tax-exempt   410,595               415,233 U.S. agency residential mortgage-backed securities   38,585               40,259 Other debt securities   205,911               220,953 Total investment securities   655,091               676,445 Available for sale securities:                     U.S. Treasury   1,015               1,015 Municipal and other tax-exempt   64,363               64,363 U.S. agency residential mortgage-backed securities   6,850,603               6,850,603 Privately issued residential mortgage-backed securities   171,493               171,493 Commercial mortgage-backed securities guaranteed by U.S. government agencies   2,141,645               2,141,645 Other debt securities   34,291               34,291 Perpetual preferred stock   24,358               24,358 Equity securities and mutual funds   19,118               19,118 Total available for sale securities   9,306,886               9,306,886 Fair value option securities:                     U.S. agency residential mortgage-backed securities   175,761               175,761 Other securities                     Total fair value option securities   175,761               175,761 Residential mortgage loans held for sale   373,253               373,253 Loans:                     Commercial   8,572,038   0.25% - 30.00%   0.60   0.53% - 4.30%   8,441,120 Commercial real estate   2,724,199   0.38% - 18.00%   0.80   1.13% - 3.66%   2,702,389 Residential mortgage   1,979,663   1.20% - 18.00%   2.42   0.57% - 4.21%   2,009,619 Personal   407,839   0.38% - 21.00%   0.46   1.07% - 3.88%   401,986 Total loans   13,683,739               13,555,114 Allowance for loan losses   (191,244 )                 Loans, net of allowance   13,492,495               13,555,114 Mortgage servicing rights   173,286               173,286 Derivative instruments with positive fair value, net of cash margin   360,809               360,809 Other assets   private equity funds   27,118               27,118 Deposits with no stated maturity   17,624,476               17,624,476 Time deposits   2,664,580   0.02% - 9.64%   2.02   0.74% - 1.31%   2,670,657 Other borrowed funds   4,595,631   0.21% - 6.68%   0.46   0.07% - 2.62%   4,555,307 Subordinated debentures   347,936   0.92% - 5.00%   2.00   2.17 %   344,764 Derivative instruments with negative fair value, net of cash margin   348,687               348,687 Because no market exists for certain of these financial instruments and management does not intend to sell these financial instruments, the fair values shown in the tables above may not represent values at which the respective financial instruments could be sold individually or in the aggregate at the given reporting date."
54,q4-15,10-Q,CORVEL CORP,874866,2015-11-05,http://www.sec.gov/Archives/edgar/data/874866/000119312515367081,No,"For the nine months ended September 30, 2015 and 2014, revenue derived from sales to The Home Depot represented 88% and 78%, respectively, of total revenue."
55,q4-15,10-Q,CORVEL CORP,874866,2015-11-05,http://www.sec.gov/Archives/edgar/data/874866/000119312515367081,No,We identify our reportable segments as those customer groups that represent more than 10% of our combined revenue or gross profit or loss of all reported operating segments.
56,q4-15,10-Q,INSIGNIA SYSTEMS INC/MN,875355,2015-10-29,http://www.sec.gov/Archives/edgar/data/875355/000110465915074002,No,"No single customer accounted for more than 10% of net sales for the three and nine months ended September 30, 2015 and 2014."
57,q4-15,10-Q,INSIGNIA SYSTEMS INC/MN,875355,2015-10-29,http://www.sec.gov/Archives/edgar/data/875355/000110465915074002,No,"Our revenues from third-party payers, the uninsured and other payers for the quarters and nine months ended September 30, 2015 and 2014 are summarized in the following table (dollars in millions):        Quarter        2015      Ratio     2014      Ratio   Medicare    $ 2,122         21.5 %    $ 2,120         23.0 %  Managed Medicare      1,031         10.5        901         9.8    Medicaid      402         4.1        372         4.0    Managed Medicaid      553         5.6        510         5.5    Managed care and other insurers      5,457         55.4        5,073         55.0    International (managed care and other insurers)      316         3.2        323         3.5                                            9,881         100.3        9,299         100.8    Uninsured      695         7.0        313         3.4    Other      438         4.4        366         4.0                                       Revenues before provision for doubtful accounts      11,014         111.7        9,978         108.2    Provision for doubtful accounts      (1,158 )       (11.7 )      (758 )       (8.2 )                                     Revenues    $     9,856         100.0 %    $     9,220         100.0 %                                          Nine Months        2015      Ratio     2014      Ratio   Medicare    $ 6,500         22.1 %    $ 6,285         23.0 %  Managed Medicare      3,099         10.5        2,706         9.9    Medicaid      1,262         4.3        1,404         5.1    Managed Medicaid      1,673         5.7        1,383         5.1    Managed care and other insurers      16,134         54.8        14,742         54.0    International (managed care and other insurers)      964         3.3        983         3.6                                            29,632         100.7        27,503         100.7    Uninsured      1,321         4.5        1,019         3.7    Other      1,315         4.5        1,097         4.0                                       Revenues before provision for doubtful accounts      32,268         109.7        29,619         108.4    Provision for doubtful accounts      (2,839 )       (9.7 )      (2,337 )       (8.4 )                                     Revenues    $     29,429         100.0 %    $     27,282         100.0 %                                     The decline in Medicaid revenues for the nine months ended September 30, 2015 compared to the nine months ended September 30, 2014 was primarily due to our recording of an adjustment to increase Medicaid revenues during the quarter ended June 30, 2014 by $142 million, or $0.20 per diluted share, related to the receipt of reimbursements in excess of our estimates for the indigent care component of the Texas Medicaid Waiver Program for the program year ended September 30, 2013."
58,q4-15,10-Q,BOK FINANCIAL CORP ET AL,875357,2015-10-30,http://www.sec.gov/Archives/edgar/data/875357/000087535715000035,No,"In connection with the sale of the Metronidazole 1.3%, the Company recognized a loss on sale of $59 million in the third quarter of 2014, as the Company s accounting policy is to not recognize contingent payments until such amounts are realizable."
59,q4-15,10-Q,BOK FINANCIAL CORP ET AL,875357,2015-10-30,http://www.sec.gov/Archives/edgar/data/875357/000087535715000035,No,"Management evaluates the Healthcare and Technology segments  performance based on net income (loss) which is impacted by the number of partner companies accounted for under the equity method, the Company s voting ownership percentage in these partner companies and the net results of operations of these partner companies, any impairment charges and gain (loss) on the sale of the interests in equity and cost method partner companies."
60,q4-15,10-Q,BOK FINANCIAL CORP ET AL,875357,2015-10-30,http://www.sec.gov/Archives/edgar/data/875357/000087535715000035,No,"For the year ended June 30, 2014, one customer accounted for approximately 58% of consolidated revenues."
61,q4-15,10-Q,BOK FINANCIAL CORP ET AL,875357,2015-10-30,http://www.sec.gov/Archives/edgar/data/875357/000087535715000035,No,"The Company accounts for such arrangements using the percentage of completion method as the Company has the ability to make reasonably dependable estimates that relate to the extent of progress toward completion, contract revenues and costs."
62,q4-15,10-Q,MDC PARTNERS INC,876883,2015-11-03,http://www.sec.gov/Archives/edgar/data/876883/000162828015008158,No,"The Company s two largest customers represented 15.3% and 10.1% of consolidated revenues for the nine months ended September 30, 2015 and 13.7% and 10.6% of consolidated revenues for the three months ended September 30, 2015."
63,q4-15,10-Q,MDC PARTNERS INC,876883,2015-11-03,http://www.sec.gov/Archives/edgar/data/876883/000162828015008158,No,"The following is a summary of our revenues by geographic region based on customer location and represents our results from continuing operations (in thousands):     Three Months Ended September 30,     Six Months Ended September 30,   Revenues by Geographic Region   2015     2014     2015     2014   North America   $ 45,176     $ 41,039     $ 87,487     $ 75,956   Europe     8,262       7,244       15,985       14,528   Asia Pacific and rest of the world     2,537       2,188       5,593       4,041   Total revenues   $ 55,975     $ 50,471     $ 109,065     $ 94,525     Significant Concentrations During the three months ended September 30, 2015, three distributors in the United States, MWI Veterinary Supply, Inc., Henry Schein Animal Health and Patterson Companies, Inc. accounted for 20%, 12% and 12%, respectively, of our total worldwide revenues."
64,q4-15,10-Q,NATIONAL HEALTH INVESTORS INC,877860,2015-11-05,http://www.sec.gov/Archives/edgar/data/877860/000087786015000087,No,"Total product sales on an individual product basis are summarized in the following table (in millions):     Three Months Ended   Nine Months Ended     September 30,   September 30,     2015   2014   2015   2014 Antiviral products:                 Harvoni   $ 3,332   $ 20   $ 10,519   $ 20 Sovaldi   1,466   2,796   3,729   8,551 Truvada   903   877   2,523   2,443 Atripla   818   895   2,334   2,545 Stribild   511   327   1,314   812 Complera/Eviplera   360   330   1,047   880 Viread   297   275   802   747 Other antiviral   15   24   53   67 Total antiviral products   7,702   5,544   22,321   16,065 Other products:                 Letairis   181   146   508   414 Ranexa   161   132   419   366 AmBisome   88   98   276   284 Zydelig   36   6   92   6 Other   43   42   126   117 Total product sales   $ 8,211   $ 5,968   $ 23,742   $ 17,252 The following table summarizes revenues from each of our customers who individually accounted for 10% or more of our total revenues (as a percentage of total revenues):     Three Months Ended   Nine Months Ended     September 30,   September 30,     2015   2014   2015   2014 McKesson Corp.   28 %   24 %   26 %   24 % AmerisourceBergen Corp.   19 %   23 %   20 %   25 % Cardinal Health, Inc.   14 %   15 %   15 %   13 % "
65,q4-15,10-Q,CHUGACH ELECTRIC ASSOCIATION INC,878004,2015-11-16,http://www.sec.gov/Archives/edgar/data/878004/000087800415000022,No,"Revenues from the Company s largest customers, as a percentage of total revenues, were as follows:       Year Ended June 30       2015     2014   Customer A     23%       21%   Customer B     15         14     Customer C     11         1     Customer D     9         21     All others     42         43           100%       100%     No other customer accounted for more than 10% of the Company s revenues in fiscal years 2015 and 2014."
66,q4-15,10-Q,SCIENTIFIC INDUSTRIES INC,87802,2015-11-12,http://www.sec.gov/Archives/edgar/data/87802/000008780215000009,No,Participating employees may contribute up to 100% of their base compensation on a pre-tax basis up to annual internal revenue service limits.
67,q4-15,10-Q,SCIENTIFIC INDUSTRIES INC,87802,2015-11-12,http://www.sec.gov/Archives/edgar/data/87802/000008780215000009,No,"For the nine-month periods ended September 30, 2015 and 2014, product revenue from customers outside the United States totaled 24 percent and 33 percent of the Company s consolidated net product revenue respectively, with 9 percent and 5 percent, respectively, representing net product revenue from customers in Germany."
68,q4-15,10-Q,NATUS MEDICAL INC,878526,2015-11-04,http://www.sec.gov/Archives/edgar/data/878526/000087852615000086,No,"For the year ended June 30, 2013, two customers accounted for 52% of consolidated revenues. "
69,q4-15,10-Q,Quadrant 4 System Corp,878802,2015-11-04,http://www.sec.gov/Archives/edgar/data/878802/000118518515002744,No,"No other class of similar products accounted for 10 percent or more of total revenues, and no other individual vendor provided more than 10 percent of total purchases. "
70,q4-15,10-Q,WIRELESS TELECOM GROUP INC,878828,2015-11-16,http://www.sec.gov/Archives/edgar/data/878828/000093041315004337,No,"The following table presents the amounts associated with such amortization:     Three months ended   September 30,   Nine months ended   September 30, (in millions)   2015   2014   2015   2014 Amortization of initial payments for new contracts   $ 14   $ 13   $ 38   $ 35 Amortization related to equity method investments   15   15   45   47   Revenue Recognition   The majority of the Company s revenues are comprised of: 1) transaction-based fees, which typically constitute a percentage of dollar volume processed; 2) fees per transaction processed; 3) fees per account on file during the period; or 4) some combination thereof."
71,q4-15,10-Q,WIRELESS TELECOM GROUP INC,878828,2015-11-16,http://www.sec.gov/Archives/edgar/data/878828/000093041315004337,No,"Customer Concentration   The percentage of total revenue recognized, which individually accounted for 10% or more of our total revenues, was as follows:         Three Months Ended September 30,   Nine Months Ended September 30, Licensee   Product Name   2015   2014   2015   2014 Genentech   Avastin   32  %   24 %   28 %   25 %     Herceptin   32  %   24 %   28 %   25 %     Xolair   10  %   6 %   8 %   6 %                       Biogen   Tysabri     11  %   10 %   10 %   9 %                       Depomed   Glumetza     (10 )%   14 %     %   13 % Foreign Currency Hedging   We enter into foreign currency hedges to manage exposures arising in the normal course of business and not for speculative purposes."
72,q4-15,10-Q,"VIVEVE MEDICAL, INC.",879682,2015-11-13,http://www.sec.gov/Archives/edgar/data/879682/000143774915020779,No,Such products represented a significant percentage of the Company s sales to The Home Depot in 2015 and 2014.
73,q4-15,10-Q,"VIVEVE MEDICAL, INC.",879682,2015-11-13,http://www.sec.gov/Archives/edgar/data/879682/000143774915020779,No,"No single customer accounted for 10% or more of ARI s revenue during the three months ended October 31, 2015 or 2014."
74,q4-15,10-Q,"VIVEVE MEDICAL, INC.",879682,2015-11-13,http://www.sec.gov/Archives/edgar/data/879682/000143774915020779,No,"Net sales recognized through Philidor represent approximately 7% and 6% of the Company's total consolidated net revenue for the three-month and nine-month periods ended September 30, 2015 , respectively, and the total assets of Philidor represent less than 1% of the Company's total consolidated assets as of September 30, 2015."
75,q4-15,10-Q,"VIVEVE MEDICAL, INC.",879682,2015-11-13,http://www.sec.gov/Archives/edgar/data/879682/000143774915020779,No,"Other than the United States, no single country accounted for more than 10% of consolidated revenues."
76,q4-15,10-Q,"VIVEVE MEDICAL, INC.",879682,2015-11-13,http://www.sec.gov/Archives/edgar/data/879682/000143774915020779,No,"Significant estimates include, among others, percentage-of-completion estimates for revenue and cost of sales recognition, incentive compensation and commissions, allowance for doubtful accounts receivable, inventory valuation reserves, warranty reserves, deferred tax valuation allowance, purchase price allocations on business acquisitions, fair value estimates of interest rate swap contracts and any impairment charges on long-lived assets and goodwill."
77,q4-15,S-1,"VIVEVE MEDICAL, INC.",879682,2015-12-16,http://www.sec.gov/Archives/edgar/data/879682/000143774915022328,No,"In 2014 and 2013, net sales for the third and fourth quarters accounted for 60% and 61% of total annual net sales, respectively."
78,q4-15,S-1,"VIVEVE MEDICAL, INC.",879682,2015-12-16,http://www.sec.gov/Archives/edgar/data/879682/000143774915022328,No,"The VA had been our largest customer, accounting for approximately 45 % and 58% of our total revenue for the years ended June 30, 2015 and 2014, respectively."
79,q4-15,S-1,"VIVEVE MEDICAL, INC.",879682,2015-12-16,http://www.sec.gov/Archives/edgar/data/879682/000143774915022328,No," H. Costs and Estimated Earnings on Long-Term Contracts   Costs and estimated earnings on long-term contracts represent unbilled revenues, including accrued profits, accounted for under the percentage-of-completion method, net of progress billings. "
80,q4-15,10-Q,DIRECT INSITE CORP,879703,2015-11-10,http://www.sec.gov/Archives/edgar/data/879703/000135448815004928,No,"Major Clients         Other than the U.S. federal government, no single client accounted for 10% or more of the Company's revenue in any of the past five fiscal years."
81,q4-15,10-Q,DIRECT INSITE CORP,879703,2015-11-10,http://www.sec.gov/Archives/edgar/data/879703/000135448815004928,No,"Revenue Recognition   The majority of the Company s revenues are comprised of: 1) transaction-based fees, which typically constitute a percentage of dollar volume processed; 2) fees per transaction processed; 3) fees per account on file during the period; or 4) some combination thereof."
82,q4-15,10-Q,DIRECT INSITE CORP,879703,2015-11-10,http://www.sec.gov/Archives/edgar/data/879703/000135448815004928,No,"During the three and nine months ended September 30, 2015, we earned revenue of $1.0 million and $92.4 million, respectively, from our relationship with Bayer, which represented 2 percent and 40 percent, respectively, of our total revenue for those periods."
83,q4-15,10-K,ARI NETWORK SERVICES INC /WI,879796,2015-10-29,http://www.sec.gov/Archives/edgar/data/879796/000087979615000024,No," The following table sets forth customers who represented 10% or more of the Company s total revenues for the three and six months ended September 30, 2015 and 2014:     Three months ended September 30,     Six months ended September 30,     2015     2014     2015     2014   INOX Wind Limited   66 %     48 %     55 %     48 % RES American Construction, Inc.   %     16 %     %    10 % Beijing JINGCHENG New Energy Co., Ltd  10 %     %     15 %    10 %                                   "
84,q4-15,10-K,ARI NETWORK SERVICES INC /WI,879796,2015-10-29,http://www.sec.gov/Archives/edgar/data/879796/000087979615000024,No," The following table summarizes revenues from each of our customers who individually accounted for 10% or more of our total revenues (as a percentage of total revenues):     Three Months Ended   Nine Months Ended     September 30,   September 30,     2015   2014   2015   2014 McKesson Corp.   28 %   24 %   26 %   24 % AmerisourceBergen Corp.   19 %   23 %   20 %   25 % Cardinal Health, Inc.   14 %   15 %   15 %   13 % "
85,q4-15,10-Q,ARI NETWORK SERVICES INC /WI,879796,2015-12-15,http://www.sec.gov/Archives/edgar/data/879796/000087979615000033,No,"Sales to one and five customers during the three months ended September 30, 2015 and 2014, accounted respectively, for approximately 76% and 99% of the Catalyst Research Instrument Operations  revenues and 8% and 33% of the Company s total revenues."
86,q4-15,10-Q,ARI NETWORK SERVICES INC /WI,879796,2015-12-15,http://www.sec.gov/Archives/edgar/data/879796/000087979615000033,No," Our revenues from third-party payers, the uninsured and other payers for the quarters and nine months ended September 30, 2015 and 2014 are summarized in the following table (dollars in millions):        Quarter        2015      Ratio     2014      Ratio   Medicare    $ 2,122         21.5 %    $ 2,120         23.0 %  Managed Medicare      1,031         10.5        901         9.8    Medicaid      402         4.1        372         4.0    Managed Medicaid      553         5.6        510         5.5    Managed care and other insurers      5,457         55.4        5,073         55.0    International (managed care and other insurers)      316         3.2        323         3.5                                            9,881         100.3        9,299         100.8    Uninsured      695         7.0        313         3.4    Other      438         4.4        366         4.0                                       Revenues before provision for doubtful accounts      11,014         111.7        9,978         108.2    Provision for doubtful accounts      (1,158 )       (11.7 )      (758 )       (8.2 )                                     Revenues    $     9,856         100.0 %    $     9,220         100.0 %                                          Nine Months        2015      Ratio     2014      Ratio   Medicare    $ 6,500         22.1 %    $ 6,285         23.0 %  Managed Medicare      3,099         10.5        2,706         9.9    Medicaid      1,262         4.3        1,404         5.1    Managed Medicaid      1,673         5.7        1,383         5.1    Managed care and other insurers      16,134         54.8        14,742         54.0    International (managed care and other insurers)      964         3.3        983         3.6                                            29,632         100.7        27,503         100.7    Uninsured      1,321         4.5        1,019         3.7    Other      1,315         4.5        1,097         4.0                                       Revenues before provision for doubtful accounts      32,268         109.7        29,619         108.4    Provision for doubtful accounts      (2,839 )       (9.7 )      (2,337 )       (8.4 )                                     Revenues    $     29,429         100.0 %    $     27,282         100.0 %                                     "
87,q4-15,10-Q,Southeastern Bank Financial CORP,880116,2015-10-23,http://www.sec.gov/Archives/edgar/data/880116/000157104915008381,No,"Pursuant to the LLC Agreement, the Company contributed $3.15 million to Three Lions in exchange for membership units representing 60% of the economic returns of Three Lions, including certain preferences with respect to common holders on operating returns and on a liquidation or sale of Three Lions."
88,q4-15,10-Q,AGCO CORP /DE,880266,2015-11-09,http://www.sec.gov/Archives/edgar/data/880266/000088026615000037,No,"No other customer accounted for more than 10 percent of net product revenue for either 2015 or 2014 or accounts receivable as of either September 30, 2015 or 2014. "
89,q4-15,497,LEGG MASON PARTNERS EQUITY TRUST,880366,2015-11-10,http://www.sec.gov/Archives/edgar/data/880366/000119312515372996,No," Note 9   Major Customers   Two customers, HP Enterprise Services ( HP ) and International Business Machines Corp. ( IBM ) accounted for a significant portion of the Company s revenues for the respective three and nine month periods ended September 30, 2015 and 2014 as follows:       For the three months ended     For the nine months ended       2015     2014     2015     2014   HP Customer A     15.7 %     14.8 %     14.7 %     14.5 % HP Customer B     11.7 %     11.9 %     11.8 %     14.3 % HP Customer C     6.6 %     6.5 %     6.3 %     8.5 % Total HP     34.0 %     33.2 %     32.8 %     37.3 % IBM     36.4 %     44.3 %     37.8 %     39.3 % Total major customers     70.4 %     77.5 %     70.6 %     76.6 % Others     29.6 %     22.5 %     29.4 %     23.4 % Total     100.0 %     100.0 %     100.0 %     100.0 %   As of September 30, 2015 and December 31, 2014, HP and IBM accounted for a significant portion of the Company s accounts receivable as follows (in thousands):       September 30, 2015     December 31, 2014   HP   $ 557     $ 1,037   IBM     467       784   Total   $ 1,024     $ 1,821   "
90,q4-15,10-Q,AMERICAN MEDIA INC,880555,2015-11-16,http://www.sec.gov/Archives/edgar/data/880555/000088055515000039,No," Customer Concentration   The percentage of total revenue recognized, which individually accounted for 10% or more of our total revenues, was as follows:         Three Months Ended September 30,   Nine Months Ended September 30, Licensee   Product Name   2015   2014   2015   2014 Genentech   Avastin   32  %   24 %   28 %   25 %     Herceptin   32  %   24 %   28 %   25 %     Xolair   10  %   6 %   8 %   6 %                       Biogen   Tysabri     11  %   10 %   10 %   9 %                       Depomed   Glumetza     (10 )%   14 %     %   13 % "
91,q4-15,10-Q,SCICLONE PHARMACEUTICALS INC,880771,2015-11-09,http://www.sec.gov/Archives/edgar/data/880771/000088077115000119,No,"No end customer accounted for 10% or more of net revenue in the three and nine months ended September 30, 2015 and 2014 ."
92,q4-15,10-Q,SCICLONE PHARMACEUTICALS INC,880771,2015-11-09,http://www.sec.gov/Archives/edgar/data/880771/000088077115000119,No,"Customers who accounted for 10% or more of our net revenues during the three months ended September 30, 2014 are as follows:     Hewlett Packard Company   30%   <p style=""font: 10pt/normal 'times new roman', times, serif; margin: 0px; text-align: left; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"">Customers who accounted for 10% or more of our net revenues during the nine months ended September 30, 2014 are as follows:     Hewlett Packard Company   16%   Kobo Inc.   10%   Netronix Inc.   10%   Leap Frog   13%       Revenue Recognition   Licensing Revenues:   We derive revenue from the licensing of internally developed intellectual property ( IP )."
93,q4-15,10-Q,"PREMIERE GLOBAL SERVICES, INC.",880804,2015-11-09,http://www.sec.gov/Archives/edgar/data/880804/000088080415000065,No,"During the nine months ended September 30, 2015, three customers accounted for 83% of the Company s revenue."
94,q4-15,10-Q,AMERICAN SUPERCONDUCTOR CORP /DE/,880807,2015-11-03,http://www.sec.gov/Archives/edgar/data/880807/000156459015009122,No,"No single customer accounted for 10% or more of ARI s revenue during the three months ended October 31, 2015 or 2014. "
95,q4-15,10-Q,AMERICAN SUPERCONDUCTOR CORP /DE/,880807,2015-11-03,http://www.sec.gov/Archives/edgar/data/880807/000156459015009122,No,"The following represents the changes for the three months ended September 30, 2015 related to assets measured at fair value on a recurring basis using significant unobservable inputs (in thousands):     Available for Sale Securities             Municipal and other tax-exempt   Other debt securities   Residential mortgage loans held for sale   Other assets   private equity funds Balance, June 30, 2015   $ 9,617   $ 4,150   $ 7,973   $ 24,399 Transfer to Level 3 from Level 2           966     Purchases and capital calls               122 Proceeds from sales           (811 )     Redemptions and distributions               (1,339 ) Gain (loss) recognized in earnings:                 Mortgage banking revenue           (95 )     Gain on other assets, net               951 Other comprehensive gain (loss):                 Net change in unrealized gain (loss)   (17 )             Balance, Sept. 30, 2015   $ 9,600   $ 4,150   $ 8,033   $ 24,133 The following represents the changes for the nine months ended September 30, 2015 related to assets measured at fair value on a recurring basis using significant unobservable inputs (in thousands):     Available for Sale Securities             Municipal and other tax-exempt   Other debt securities   Residential mortgage loans held for sale   Other assets   private equity funds Balance, Dec. 31, 2014   $ 10,093   $ 4,150   $ 11,856   $ 25,627 Transfer to Level 3 from Level 2           2,153     Purchases and capital calls               720 Proceeds from sales           (6,099 )     Redemptions and distributions   (500 )           (4,689 ) Gain (loss) recognized in earnings:                 Mortgage banking revenue           123     Gain on other assets, net               2,475 Other comprehensive gain (loss):                 Net change in unrealized gain (loss)   7             Balance, Sept. 30, 2015   $ 9,600   $ 4,150   $ 8,033   $ 24,133 The following represents the changes for the three months ended September 30, 2014 related to assets measured at fair value on a recurring basis using significant unobservable inputs (in thousands):     Available for Sale Securities             Municipal and other tax-exempt   Other debt securities   Equity securities and mutual funds   Residential mortgage loans held for sale   Other assets   private equity funds Balance, June 30, 2014   $ 10,445   $ 4,231   $     $     $ 27,833 Transfer to Level 3 from Level 2               7,764     Purchases and capital calls                   505 Redemptions and distributions                   (1,994 ) Gain (loss) recognized in earnings                     Mortgage banking revenue               (388 )     Gain on other assets, net                   774 Loss on available for sale securities, net                     Charitable contributions to BOKF Foundation                     Other comprehensive gain (loss):                     Net change in unrealized gain (loss)   (252 )   (81 )             Balance, Sept. 30, 2014   $ 10,193   $ 4,150   $     $ 7,376   $ 27,118 The following represents the changes for the nine months ended September 30, 2014 related to assets measured at fair value on a recurring basis using significant unobservable inputs (in thousands):     Available for Sale Securities             Municipal and other tax-exempt   Other debt securities   Equity securities and mutual funds   Residential mortgage loans held for sale   Other assets   private equity funds Balance, Dec. 31, 2013   $ 17,805   $ 4,712   $ 4,207   $     $ 27,341 Transfer to Level 3 from Level 2               7,764     Purchases, and capital calls                   930 Redemptions and distributions   (7,487 )   (500 )           (5,175 ) Gain (loss) recognized in earnings                     Mortgage banking revenue               (388 )     Gain on other assets, net                   4,022 Loss on available for sale securities, net   (235 )                 Charitable contributions to BOKF Foundation           (2,420 )         Other comprehensive gain (loss):                     Net change in unrealized gain (loss)   110   (62 )   (1,787 )         Balance, Sept. 30, 2014   $ 10,193   $ 4,150   $     $ 7,376   $ 27,118 A summary of quantitative information about assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of September 30, 2015 follows (in thousands):     Par Value   Amortized Cost/Unpaid Principal Balance   Fair Value   Valuation Technique(s)   Unobservable Input   Range (Weighted Average)                               Available for sale securities                           Municipal and other tax-exempt securities   $ 10,370   $ 10,310   $ 9,600   Discounted cash flows 1   Interest rate spread   5.23%-5.53% (5.49%) 2   92.35%-92.73% (92.57%) 3   Other debt securities   4,400   4,400   4,150   Discounted cash flows 1   Interest rate spread   5.65%-5.70% (5.69%) 4   94.32% - 94.33 (94.33%) 3                               Residential mortgage loans held for sale   N/A   8,538   8,033   Quoted prices of loans sold in securitization transactions, with a liquidity discount applied   Liquidity discount applied to the market value of a mortgage loans qualifying for sale to U.S. government agencies."
96,q4-15,10-Q,ABAXIS INC,881890,2015-11-09,http://www.sec.gov/Archives/edgar/data/881890/000114036115040208,No,"Significant estimates in these consolidated financial statements include percentage-of-completion for construction projects; allowances for doubtful accounts receivable and sales returns; inventory and project asset write-downs; stock-based compensation; estimates for future cash flows and economic useful lives of property, plant and equipment, goodwill, valuations for business combinations, other intangible assets and other long-term assets; the fair value and residual value of leased solar power systems; fair value of financial instruments; valuation of contingencies and certain accrued liabilities such as accrued warranty; and income taxes and tax valuation allowances."
97,q4-15,10-Q,ABAXIS INC,881890,2015-11-09,http://www.sec.gov/Archives/edgar/data/881890/000114036115040208,No," Changes in Estimates The majority of the Company s sales are accounted for as long-term contracts, which are accounted for using the percentage-of-completion method (""POC"")."
98,q4-15,10-Q,ABAXIS INC,881890,2015-11-09,http://www.sec.gov/Archives/edgar/data/881890/000114036115040208,No,"During the nine months ended September 30, 2015, one customer accounted for 35% of the Company s total net sales."
99,q4-15,10-Q,ABAXIS INC,881890,2015-11-09,http://www.sec.gov/Archives/edgar/data/881890/000114036115040208,No,"Three Months Ended September 30, 2015 Isis Core   Akcea Therapeutics     Elimination of Intercompany Activity   Total               Revenue:           Research and development   $ 52,104     $       $ (3,186 )   $ 48,918   Licensing and royalty     203                       203   Total segment revenue   $ 52,307     $       $ (3,186 )   $ 49,121   Loss from operations   $ (37,183 )   $ (14,621 )   $ 3,186     $ (48,618 ) Nine Months Ended September 30, 2015 Isis Core   Akcea Therapeutics     Elimination of Intercompany Activity   Total               Revenue:           Research and development   $ 233,655     $       $ (3,186 )   $ 230,469   Licensing and royalty     1,664                       1,664   Total segment revenue   $ 235,319     $       $ (3,186 )   $ 232,133   Loss from operations   $ 14,174     $ (30,661 )   $ 3,186     $ (13,301 ) The following is our segment information for the three and nine months ended September 30, 2014 (in thousands) revised for comparative purposes to show operating costs for Akcea-related projects in 2014: Three Months Ended September 30, 2014 Isis Core   Akcea Therapeutics   Total           Revenue:       Research and development   $ 43,798     $       $ 43,798   Licensing and royalty     265               265   Total segment revenue   $ 44,063     $       $ 44,063   Loss from operations   $ (14,886 )   $ (6,607 )   $ (21,493 ) Nine Months Ended September 30, 2014 Isis Core   Akcea Therapeutics   Total           Revenue:       Research and development   $ 119,975     $       $ 119,975   Licensing and royalty     9,325               9,325   Total segment revenue   $ 129,300     $       $ 129,300   Loss from operations   $ (41,609 )   $ (16,202 )   $ (57,811 ) We have historically funded our operations from collaborations with corporate partners and a relatively small number of partners have accounted for a significant percentage of our revenue."
100,q4-15,10-Q,ABAXIS INC,881890,2015-11-09,http://www.sec.gov/Archives/edgar/data/881890/000114036115040208,No," The following distributors and customers accounted for 10% or more of the Company's revenue for the periods presented:   Three Months Ended   Nine Months Ended   September 27, 2015   September 28, 2014   September 27, 2015   September 28, 2014 Distributor ""A"" 15 %   26 %   24 %   15 % Distributor ""B"" *   12 %   *   * Customer ""B"" 10 %   13 %   14 %   * Customer ""G"" 57 %   27 %   44 %   53 %   * Represents less than 10% of revenue for the period presented. "
101,q4-15,10-Q,GILEAD SCIENCES INC,882095,2015-11-04,http://www.sec.gov/Archives/edgar/data/882095/000088209515000033,No,"During the year ended December 31, 2014, two customers accounted for 91% of the Company s revenue."
102,q4-15,10-Q,GILEAD SCIENCES INC,882095,2015-11-04,http://www.sec.gov/Archives/edgar/data/882095/000088209515000033,No,"Our revenues are principally generated from the sale of OTC heath care and cold remedy products which represented approximately 89% and 95% of total revenues for the nine months ended September 30, 2015 and 2014, respectively."
103,q4-15,10-Q,"PDL BIOPHARMA, INC.",882104,2015-11-04,http://www.sec.gov/Archives/edgar/data/882104/000088210415000079,No,"During the nine months ended September 30, 2014, three customers accounted for 94% of the Company s revenue. "
104,q4-15,10-Q,"PDL BIOPHARMA, INC.",882104,2015-11-04,http://www.sec.gov/Archives/edgar/data/882104/000088210415000079,No,"Borrowings under the Credit Facility are subject to a borrowing base limited to the lesser of (A) $170.0 million; or (B) the sum of (i) 90% of eligible investment grade accounts receivable (reduced to 85% in certain situations), plus (ii) 85% of eligible non-investment grade accounts receivable, plus (iii) the lesser of (a) 85% of eligible unbilled accounts receivable and (b) $10.0 million, plus (iv) the product of 85% multiplied by the net orderly liquidation value percentage applied to the net book value of eligible revenue equipment, plus (v) 85% multiplied the net book value of otherwise eligible newly acquired revenue equipment that has not yet been subject to an appraisal."
105,q4-15,10-Q,"PDL BIOPHARMA, INC.",882104,2015-11-04,http://www.sec.gov/Archives/edgar/data/882104/000088210415000079,No,"Of our total revenues for the three and nine months ended September 30, 2015, we recorded $9,855,000 ( 17% ) and $29,566,000 ( 17% ), respectively, in lease revenue from Senior Living, of which $2,105,000 and $6,316,000 respectively, represented straight-line rent."
106,q4-15,10-Q,"PDL BIOPHARMA, INC.",882104,2015-11-04,http://www.sec.gov/Archives/edgar/data/882104/000088210415000079,No,"As of November  6 , 2015, distribution rights in the U.S. representing approximately 89% of the target case sales have been transitioned to TCCC s distribution network."
107,q4-15,10-Q,"POWERSECURE INTERNATIONAL, INC.",882154,2015-11-04,http://www.sec.gov/Archives/edgar/data/882154/000119312515366141,No," ACCOUNTS RECEIVABLE SALES AGREEMENTS As of September 30, 2015 and December 31, 2014 , the Company had accounts receivable sales agreements that permit the sale, on an ongoing basis, of a majority of its wholesale receivables in North America and Europe to its 49% owned U.S., Canadian and European finance joint ventures."
108,q4-15,10-Q,"POWERSECURE INTERNATIONAL, INC.",882154,2015-11-04,http://www.sec.gov/Archives/edgar/data/882154/000119312515366141,No,"Customers who accounted for 10% or more of our net revenues during the three months ended September 30, 2015 are as follows:     Barnes   Noble   22%   Hewlett Packard Company   21%   Autoliv Development AB   18%   Customers who accounted for 10% or more of our net revenues during the nine months ended September 30, 2015 are as follows:   <table style=""font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0px; margin-bottom: 0px; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"" cellspacing=""0"" cellpadding=""0"">   Hewlett Packard Company  26%   Amazon   15%   Autoliv Development AB   18%   Our net revenues for the three and nine months ended September 30, 2014 were earned from sixteen and twenty-eight customers."
109,q4-15,10-Q,"POWERSECURE INTERNATIONAL, INC.",882154,2015-11-04,http://www.sec.gov/Archives/edgar/data/882154/000119312515366141,No,No single customer accounted for 10% or more of ARI s revenue in fiscal 2015 or fiscal 2014.
110,q4-15,10-Q,QUICKLOGIC CORPORATION,882508,2015-11-03,http://www.sec.gov/Archives/edgar/data/882508/000088250815000035,No,"The Company had one distributor that accounted for 18% of net revenue in the three months ended September 30, 2015 ."
111,q4-15,10-Q,QUICKLOGIC CORPORATION,882508,2015-11-03,http://www.sec.gov/Archives/edgar/data/882508/000088250815000035,No,"For the three-month and nine-month periods ended September 30, 2014, one individual customer accounted for 72 percent and 67 percent of net product revenue, respectively."
112,q4-15,10-Q,BIOCRYST PHARMACEUTICALS INC,882796,2015-11-06,http://www.sec.gov/Archives/edgar/data/882796/000117184315006102,No,"September 30, 2015             Gross     Gross             Amortized     unrealized     unrealized     Estimated       cost     gains     losses     fair value   Available-for-sale   (Dollars in thousands)   Obligations of U.S. Government agencies   $ 164,365       401       (772 )     163,994   Obligations of states and political subdivisions     131,471       3,535       (444 )     134,562   Mortgage backed securities                                 U.S. GSE's* MBS - residential     135,081       1,614       (456 )     136,239   U.S. GSE's CMO     146,382       1,572       (266 )     147,688   Corporate bonds     114,608       857       (954 )     114,511       $ 691,907       7,979       (2,892 )     696,994     * Government sponsored entities       December 31, 2014             Gross     Gross             Amortized     unrealized     unrealized     Estimated       cost     gains     losses     fair value   Available-for-sale   (Dollars in thousands)   Obligations of U.S. Government agencies   $ 181,104       307       (2,667 )     178,744   Obligations of states and political subdivisions     98,538       3,400       (183 )     101,755   Mortgage backed securities                                 U.S. GSE's MBS - residential     128,891       1,672       (527 )     130,036   U.S. GSE's CMO     123,921       983       (443 )     124,461   Corporate bonds     109,936       990       (1,457 )     109,469       $ 642,390       7,352       (5,277 )     644,465     As of September 30, 2015, except for the U.S. Government agencies and government sponsored entities, there was no issuer who represented 10% or more of stockholders  equity within the investment portfolio."
113,q4-15,10-Q/A,"Pacific Ventures Group, Inc.",882800,2015-12-03,http://www.sec.gov/Archives/edgar/data/882800/000107997415000845,No,"During the six months ended September 30, 2015, three distributors in the United States, MWI Veterinary Supply, Inc., Henry Schein Animal Health and Patterson Companies, Inc. accounted for 20%, 12% and 10%, respectively, of our total worldwide revenues."
114,q4-15,10-K,SYNOPSYS INC,883241,2015-12-14,http://www.sec.gov/Archives/edgar/data/883241/000088324115000014,No,"Revenues from the Company s largest customers, as a percentage of total revenues, were as follows:       Year Ended June 30       2015     2014   Customer A     23%       21%   Customer B     15         14     Customer C     11         1     Customer D     9         21     All others     42         43           100%       100%     No other customer accounted for more than 10% of the Company s revenues in fiscal years 2015 and 2014. "
115,q4-15,10-K,SYNOPSYS INC,883241,2015-12-14,http://www.sec.gov/Archives/edgar/data/883241/000088324115000014,No,"No other customer accounted for more than 10 percent of net product revenue for either 2015 or 2014 or accounts receivable as of either September 30, 2015 or 2014."
116,q4-15,10-K,NCI BUILDING SYSTEMS INC,883902,2015-12-22,http://www.sec.gov/Archives/edgar/data/883902/000088390215000009,No,"During the three months ended September 30, 2015, three customers accounted for 93% of the Company s revenue."
117,q4-15,10-Q,USA TRUCK INC,883945,2015-11-04,http://www.sec.gov/Archives/edgar/data/883945/000143774915019652,No,"For the year ended June 30, 2013, two customers accounted for 52% of consolidated revenues."
118,q4-15,10-Q,FIRST DATA CORP,883980,2015-11-10,http://www.sec.gov/Archives/edgar/data/883980/000162828015008616,No,"Our revenues from third-party payers, the uninsured and other payers for the quarters and nine months ended September 30, 2015 and 2014 are summarized in the following table (dollars in millions):        Quarter        2015      Ratio     2014      Ratio   Medicare    $ 2,122         21.5 %    $ 2,120         23.0 %  Managed Medicare      1,031         10.5        901         9.8    Medicaid      402         4.1        372         4.0    Managed Medicaid      553         5.6        510         5.5    Managed care and other insurers      5,457         55.4        5,073         55.0    International (managed care and other insurers)      316         3.2        323         3.5                                            9,881         100.3        9,299         100.8    Uninsured      695         7.0        313         3.4    Other      438         4.4        366         4.0                                       Revenues before provision for doubtful accounts      11,014         111.7        9,978         108.2    Provision for doubtful accounts      (1,158 )       (11.7 )      (758 )       (8.2 )                                     Revenues    $     9,856         100.0 %    $     9,220         100.0 %                                          Nine Months        2015      Ratio     2014      Ratio   Medicare    $ 6,500         22.1 %    $ 6,285         23.0 %  Managed Medicare      3,099         10.5        2,706         9.9    Medicaid      1,262         4.3        1,404         5.1    Managed Medicaid      1,673         5.7        1,383         5.1    Managed care and other insurers      16,134         54.8        14,742         54.0    International (managed care and other insurers)      964         3.3        983         3.6                                            29,632         100.7        27,503         100.7    Uninsured      1,321         4.5        1,019         3.7    Other      1,315         4.5        1,097         4.0                                       Revenues before provision for doubtful accounts      32,268         109.7        29,619         108.4    Provision for doubtful accounts      (2,839 )       (9.7 )      (2,337 )       (8.4 )                                     Revenues    $     29,429         100.0 %    $     27,282         100.0 %                                     The decline in Medicaid revenues for the nine months ended September 30, 2015 compared to the nine months ended September 30, 2014 was primarily due to our recording of an adjustment to increase Medicaid revenues during the quarter ended June 30, 2014 by $142 million, or $0.20 per diluted share, related to the receipt of reimbursements in excess of our estimates for the indigent care component of the Texas Medicaid Waiver Program for the program year ended September 30, 2013. "
119,q4-15,10-Q,FIRST DATA CORP,883980,2015-11-10,http://www.sec.gov/Archives/edgar/data/883980/000162828015008616,No,"The Company had one distributor that accounted for 18% of net revenue in the nine months ended September 30, 2015 ."
120,q4-15,S-1/A,FIRST DATA CORP,883980,2015-10-01,http://www.sec.gov/Archives/edgar/data/883980/000119312515334479,No,"Sinopharm contributed 98% and 94% of the Company s total net revenue for the three-month periods ended September 30, 2015 and 2014, respectively."
121,q4-15,S-1/A,FIRST DATA CORP,883980,2015-10-01,http://www.sec.gov/Archives/edgar/data/883980/000119312515334479,No,"The following represents a summary of mortgage servicing rights (Dollars in thousands):     September 30, 2015   Dec. 31, 2014   September 30, 2014 Number of residential mortgage loans serviced for others   128,828   117,483   114,493 Outstanding principal balance of residential mortgage loans serviced for others   $ 18,928,726   $ 16,162,887   $ 15,499,653 Weighted average interest rate   4.15 %   4.29 %   4.33 % Remaining term (in months)   300   296   295 Activity in capitalized mortgage servicing rights during the three months ended September 30, 2015 was as follows (in thousands):     Purchased   Originated   Total Balance, June 30, 2015   $ 10,730   $ 187,964   $ 198,694 Additions, net       19,993   19,993 Change in fair value due to loan runoff   (661 )   (6,220 )   (6,881 ) Change in fair value due to market changes   (656 )   (11,101 )   (11,757 ) Balance, Sept. 30, 2015   $ 9,413   $ 190,636   $ 200,049 Activity in capitalized mortgage servicing rights during the nine months ended September 30, 2015 was as follows (in thousands):     Purchased   Originated   Total Balance, Dec. 31, 2014   $ 11,114   $ 160,862   $ 171,976 Additions, net       62,375   62,375 Change in fair value due to loan runoff   (2,171 )   (19,862 )   (22,033 ) Change in fair value due to market changes   470   (12,739 )   (12,269 ) Balance, Sept. 30, 2015   $ 9,413   $ 190,636   $ 200,049 Activity in capitalized mortgage servicing rights during the three months ended September 30, 2014 was as follows (in thousands):     Purchased   Originated   Total Balance, June 30, 2014   $ 13,082   $ 142,658   $ 155,740 Additions, net       17,367   17,367 Change in fair value due to loan runoff   (624 )   (4,478 )   (5,102 ) Change in fair value due to market changes   821   4,460   5,281 Balance, Sept. 30, 2014   $ 13,279   $ 160,007   $ 173,286 Activity in capitalized mortgage servicing rights during the nine months ended September 30, 2014 was as follows (in thousands):     Purchased   Originated   Total Balance, Dec. 31, 2013   $ 15,935   $ 137,398   $ 153,333 Additions, net       39,183   39,183 Change in fair value due to loan runoff   (1,737 )   (11,869 )   (13,606 ) Change in fair value due to market changes   (919 )   (4,705 )   (5,624 ) Balance, Sept. 30, 2014   $ 13,279   $ 160,007   $ 173,286 Changes in the fair value of mortgage servicing rights are included in Other operating revenue in the Consolidated Statements of Earnings."
122,q4-15,S-1/A,FIRST DATA CORP,883980,2015-10-01,http://www.sec.gov/Archives/edgar/data/883980/000119312515334479,No,"Year ended December 31, (in millions)   2014   2013   2012 Net operating revenues   $ 1,357   $ 1,369   $ 1,278 Operating expenses   638   675   630 Operating income   $ 719   $ 694   $ 648 Net income   $ 696   $ 664   $ 639 FDC equity earnings   220   188   158   The formation of a merchant alliance accounted for under the equity method of accounting generally involves the Company and/or a financial institution contributing merchant contracts to the alliance and a cash payment from one owner to the other to achieve the desired ownership percentages."
123,q4-15,10-K,UGI CORP /PA/,884614,2015-11-30,http://www.sec.gov/Archives/edgar/data/884614/000088461415000034,No,"No one customer accounted for 10% or more of revenue during the six months ended September 30, 2014 or 2015. "
124,q4-15,10-K,UGI CORP /PA/,884614,2015-11-30,http://www.sec.gov/Archives/edgar/data/884614/000088461415000034,No,"The Company is to remit 2% of revenues and accounts receivables daily until the entire balance of $31,970 has been received."
125,q4-15,10-K,UGI CORP /PA/,884614,2015-11-30,http://www.sec.gov/Archives/edgar/data/884614/000088461415000034,No," The following customers accounted for more than 10% of the Company's total revenues:         Three Months Ended   Nine Months Ended   September 30,   September 30,   2015   2014   2015   2014 Nokia Networks 14.1 %   13.0 %   19.5 %   16.5 % Philips Healthcare N/A   18.7 %   N/A   16.4 % An Asian Carrier 14.2 %   10.6 %   N/A   N/A "
126,q4-15,10-Q,COTT CORP /CN/,884713,2015-11-12,http://www.sec.gov/Archives/edgar/data/884713/000119312515374578,No,"H. Costs and Estimated Earnings on Long-Term Contracts   Costs and estimated earnings on long-term contracts represent unbilled revenues, including accrued profits, accounted for under the percentage-of-completion method, net of progress billings."
127,q4-15,10-Q,COTT CORP /CN/,884713,2015-11-12,http://www.sec.gov/Archives/edgar/data/884713/000119312515374578,No,"For the three-month periods ended September 30, 2015 and 2014, net product revenue from customers outside the United States totaled 27 percent and 28 percent of the Company s consolidated net product revenue, respectively, with 9 percent and 17 percent, respectively, representing product revenue from customers in Germany."
128,q4-15,10-Q,ARIAD PHARMACEUTICALS INC,884731,2015-11-06,http://www.sec.gov/Archives/edgar/data/884731/000119312515370277,No,These three pharmaceutical specialty distributors accounted for greater than 90% of all RAPIVAB product sales to date and accounted for predominantly all of the Company s outstanding receivables from product sales.
129,q4-15,10-Q,ARIAD PHARMACEUTICALS INC,884731,2015-11-06,http://www.sec.gov/Archives/edgar/data/884731/000119312515370277,No,"Because the percentage-of-completion method of accounting relies upon estimates as described above, recognized revenues and profits are subject to revision as a project progresses to completion."
130,q4-15,10-Q,ARIAD PHARMACEUTICALS INC,884731,2015-11-06,http://www.sec.gov/Archives/edgar/data/884731/000119312515370277,No,"During the three months ended September 30, 2014, one distributor in the United States, MWI Veterinary Supply, accounted for 20% of our total worldwide revenues."
131,q4-15,10-Q,ARIAD PHARMACEUTICALS INC,884731,2015-11-06,http://www.sec.gov/Archives/edgar/data/884731/000119312515370277,No,"During the nine months ended September 30, 2014, two customers accounted for 30% and 12% of the Company s total net sales."
132,q4-15,10-Q,ARIAD PHARMACEUTICALS INC,884731,2015-11-06,http://www.sec.gov/Archives/edgar/data/884731/000119312515370277,No,"The Company had one distributor that accounted for 15% of net revenue in the three months ended September 30, 2014 ."
133,q4-15,10-Q,ARIAD PHARMACEUTICALS INC,884731,2015-11-06,http://www.sec.gov/Archives/edgar/data/884731/000119312515370277,No,"No clients accounted for 10% of the Company s revenue for the three and nine months ended September 30, 2015 or for the three and nine months ended September 30, 2014 . "
134,q4-15,10-K,AUTHENTIDATE HOLDING CORP,885074,2015-10-13,http://www.sec.gov/Archives/edgar/data/885074/000119312515342743,No,"During the three months ended September 30, 2014, two customers accounted for 79% of the Company s revenue."
135,q4-15,10-K,AUTHENTIDATE HOLDING CORP,885074,2015-10-13,http://www.sec.gov/Archives/edgar/data/885074/000119312515342743,No,"Under the terms of the Escrow Agreement and the transition payment agreement entered into in connection therewith, if the distribution rights in the U.S. that are transitioned to TCCC s distribution network represent case sales in excess of the following percentages of a target case sale amount agreed to by the parties, amounts in the escrow fund in excess of the applicable amounts below will be released to the Company:   Percentage Transitioned      Escrow Release 40% Amounts in excess of $375 million 50% Amounts in excess of $312.5 million 60% Amounts in excess of $250 million 70% Amounts in excess of $187.5 million 80% Amounts in excess of $125 million 90% Amounts in excess of $62.5 million 95% All remaining amounts   On the one-year anniversary of the closing of the TCCC Transaction, the then-remaining escrow amount, less an amount sufficient to cover any unresolved claims, will be released to TCCC."
136,q4-15,10-K,AUTHENTIDATE HOLDING CORP,885074,2015-10-13,http://www.sec.gov/Archives/edgar/data/885074/000119312515342743,No,"CCR accounted for approximately 41% and 29% of the Company s net sales for the nine-months ended September 30, 2015 and 2014, respectively."
137,q4-15,10-K,AUTHENTIDATE HOLDING CORP,885074,2015-10-13,http://www.sec.gov/Archives/edgar/data/885074/000119312515342743,No,"As described in Note 9, the Company has two major customers that accounted for 70.4% and 77.5% of the Company s revenue for the three months ended September 30, 2015 and 2014, respectively, and 70.6% and 76.6% of the Company s revenue for the nine months ended September 30, 2015 and 2014, respectively."
138,q4-15,10-K,AUTHENTIDATE HOLDING CORP,885074,2015-10-13,http://www.sec.gov/Archives/edgar/data/885074/000119312515342743,No,No single customer accounted for 10% or more of ARI s revenue in fiscal 2015 or fiscal 2014.  
139,q4-15,10-Q,CYNOSURE INC,885306,2015-11-06,http://www.sec.gov/Archives/edgar/data/885306/000119312515370071,No,"Customers who accounted for 10% or more of our net revenues during the three months ended September 30, 2014 are as follows:     Hewlett Packard Company   30%   Customers who accounted for 10% or more of our net revenues during the nine months ended September 30, 2014 are as follows:     Hewlett Packard Company   16%   Kobo Inc.   10%   Netronix Inc.   10% <table style=""font: 10pt/normal 'times new roman', times, serif; width: 100%; text-transform: none; text-indent: 0px; letter-spacing: normal; margin-top: 0px; margin-bottom: 0px; word-spacing: 0px; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;"" cellspacing=""0"" cellpadding=""0"">   Leap Frog   13% "
140,q4-15,10-Q,ANCHOR BANCORP WISCONSIN INC,885322,2015-11-05,http://www.sec.gov/Archives/edgar/data/885322/000162828015008354,No,"Including the fuel component, this contract represented $26.1 million of sales revenue through April 30 , 2015, and $ 70.7 million, or 26 percent, of sales revenue in 2014."
141,q4-15,10-Q,"Valeant Pharmaceuticals International, Inc.",885590,2015-10-26,http://www.sec.gov/Archives/edgar/data/885590/000088559015000077,No," Risk and Uncertainties: In fiscal 2015, one class of similar products accounted for approximately 11 percent of the Company s total revenues, and one vendor supplied approximately 11 percent of the Company s total purchases."
142,q4-15,10-Q,"Valeant Pharmaceuticals International, Inc.",885590,2015-10-26,http://www.sec.gov/Archives/edgar/data/885590/000088559015000077,No,"On October 20, 2009, the Company issued and sold to Clayton, Dubilier   Rice Fund VIII, L.P. and CD R Friends   Family Fund VIII, L.P. (together, the  CD R Funds ), an aggregate of 250,000 shares of a newly created class of convertible preferred stock, par value $1.00 per share, of the Company, designated the Series B Cumulative Convertible Participating Preferred Stock (the  Convertible Preferred Stock,  and shares thereof, the  Preferred Shares ), initially representing approximately 68.4% of the voting power and common stock of the Company on an as-converted basis (such purchase and sale, the  Equity Investment )."
